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Summary 
Complex and differential gene expression programs give rise to several cell types that 
constitute the different parts of the organism. This cell fate determination is controlled by a 
group of proteins, named transcription regulators (TRs). Our group investigates the molecular 
mechanisms underlying neurogenesis using the zebrafish as a model system. To that purpose, 
a genome-wide analysis of TR gene expression was performed in our laboratory, and 
hundreds of these regulators were identified. On the basis of these initial studies, a number of 
TRs were selected for further characterization. For this project, two model systems for 
zebrafish neurogenesis were chosen: The embryonic spinal cord and the adult telencephalon. 
The spinal cord is considered as relatively simple and is used to understand the neural 
differentiation and function in vertebrates during development. Based on morpholinos 
knockdown experiments, two closely related genes sox1a and sox1b encoding transcription 
factors, were shown to play a role in the specification of a newly observed sub-type of 
interneurons, named V2c, in the ventral spinal cord of the zebrafish. Nevertheless, the 
epistatic relationship between these genes has still to be investigated. On the other hand, in the 
adult brain, new neurons are continuously generated from neural progenitor cells. The 
zebrafish brain contains many more progenitor zones compared to mammals, reflecting its 
great capacity of neuronal proliferation and regeneration. Focusing on the telencephalic zones, 
because of its similarities with the mammalian brain, several factors were identified with a 
potential role in adult neurogenesis. Among those regulators, Id1 that acts as a dominant 
negative factor for basic helix-loop-helix (bHLH) transcription factors was chosen for further 
investigations because of promising previous observations using morpholino knockdown and 
protein overexpression methods. However, in order to perform loss-of-function studies and to 
deepen our understanding about the role of chosen TR genes and their molecular mechanisms 
controlling neurogenesis and adult brain regeneration, newly developed tools for gene 
manipulation were used: The transcription activator-like effector nucleases (TALENs) and the 
Type II clustered regulatory interspaced short palindromic repeats (CRISPR). Both methods 
use the nuclease activity to create double-stranded-breaks (DSBs) that are repaired via an 
error-prone pathway, non-homologous end-joining (NHEJ), creating mismatches in the DNA, 
or via a homologous recombination (HR) pathway allowing incorporation of a DNA sequence 
in a specific location of the genome.  
II 
 
After implementation of these two methods shortly after their development, I could show the 
efficiency of both in inducing mutations in the zebrafish genome, thus by using the gene no-
tail (ntl) as a proof of principle. I then created with TALENs heritable mutations in the gene 
id1 and assessed three generations of progeny in order to select a knockout line for the cited 
gene. Mutations in id3 were also induced with both TALENs and CRISPR and other id genes 
were selected in order to continue the study concerning their possible redundant activities and 
their implication in adult neurogenesis and brain regeneration in the zebrafish. In parallel, I 
used the CRISPR system to simultaneously mutate the genes sox1a and sox1b in order to 
confirm their role in the specification of interneurons in the zebrafish spinal cord. Considering 
the long-lasting lack of site-specific mutagenesis in zebrafish and the controversies in the last 
few years about the specificity of the morpholino antisense technology, the new genetic tools 
characterized and applied in this PhD work open the door to a wide range of investigations.  
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Zusammenfassung 
Alle Zellen eines Organismus enthalten die gleichen Erbanlagen. Die DNA und die darin 
enthaltenen Gene sind folglich in allen Zellen identisch. Erst die differenzierte Expression 
dieser Gene führt zur Bildung von unterschiedlichen Zelltypen, die die Grundlagen für die 
verschiedenen Gewebe eines Organismus darstellen. Diese komplexe Expressionskontrolle 
beruht auf einer Gruppe von Proteinen die man Transkriptionsregulatoren (TR) nennt. Um die 
Rolle von verschiedenen TR in der Neurogenese des Zebrafisches zu untersuchen, wurden für 
die vorliegende Arbeit zwei Modelsysteme herangezogen: das embryonale Rückenmark und 
das adulte Telencephalon. Das Rückenmark wird als relative einfache Struktur angesehen und 
wurde verwendet um die neuronale Differenzierung in Vertebraten während der embryonalen 
Entwicklung verstehen zu lernen. Für zwei eng verwandte Gene, sox1a und sox1b, die für 
Transkriptionsfaktoren kodieren, konnte anhand von Morpholino Experimenten gezeigt 
werden, dass sie eine Rolle bei der Spezifizierung eines neuen interneuronalen Subtypus, V2c, 
spielen, der im ventralen Rückenmark des Zebrafisches lokalisiert ist. Jedoch muss die 
epistatische Beziehung der beiden Gene untereinander noch untersucht werden. Im adulten 
Gehirn werden Neuronen kontinuierlich aus neuronalen Stammzellen gebildet. Das Gehirn 
des Zebrafisches enthält, verglichen mit dem von Säugetieren, erheblich mehr proliferierende 
Zonen, was sein enormes Vermögen in der neuronalen Proliferation und Regeneration 
aufzeigt. Da das Gehirn des Zebrafisches Ähnlichkeiten mit dem Säugergehirn aufweist, hat 
unsere Arbeitsgruppe den Blick auf Regionen des Telencephalons gerichtet und mehrere 
Faktoren isoliert, die möglicherweise eine Rolle in der Neurogenese spielen. Unter diesen 
Faktoren befindet sich das auf Transkriptionsfaktoren dominant-negativ agierende id1. Da id1 
spezifisch in der ventrikulären Zone des Telencephalons exprimiert wird (eine proliferierende 
Zone im Gehirn des Zebrafisches) und die Tatsache das id1 im verletzten Gehirn 
hochreguliert wird, wurde der Faktor für eine eingehendere Untersuchung ausgewählt. Um ein 
tiefergehendes Verständnis zur Funktion und den molekularen Mechanismen welche die 
Regeneration im adulten Gehirn steuern, wurden loss-of-function Studien durchgeführt, die 
auf neu entwickelten Werkzeugen zur Genmanipulation basieren: transcription activator-like 
effector nucleases (TALENs) und Type II clustered regulatory interspaced short palindromic 
repeats (CRISPR). Beide Methoden verwenden die Aktivität einer Nuklease um 
Doppelstrangbrüche zu erzeugen, die entweder durch das fehleranfällige non-homologous 
end-joining (NHEJ) repariert werden, bei dem es zu Fehlpaarungen kommen kann, oder durch 
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homologe Rekombination (HR), welche den Einbau von DNA Sequenzen an spezifischen 
Stellen im Genom erlaubt. 
Nach der Etablierung dieser zwei Methoden schon kurz nach deren Entwicklung, 
konnte ich am Beispiel des notail (ntl) Lokus die Effizienz beider Techniken bei der 
Induktion von Mutationen im Zebrafischgenom demonstrieren. Im Anschluss habe ich in die 
Keimbahn reichende Mutationen im id1 Gen eingefügt und die Nachkommen der drei 
folgenden Generationen nach einem erfolgreichen knock-out von id1 selektioniert. Im 
Folgenden wurde, um die Rolle weiterer Mitglieder aus der id-Familie zu untersuchen und 
deren mögliche Redundanz zu ergründen, Mutationen in id3 mit Hilfe von TALENs und 
CRISPR eingefügt. Parallel dazu verwand ich das CRISPR System um die Gene sox1a und 
sox1b zeitgleich zu mutieren. Damit sollte ihre Rolle bei der Spezifikation von Interneuronen 
im Rückenmark des Zebrafisches bestätigt werden, die die vorläufigen Morpholino 
Experimente angedeutet hatten. Bedenkt man, dass es lange Zeit nicht möglich war gerichtete 
Mutagenese im Zebrafisch durchzuführen und die Kontroversen der letzten Jahre, ob der 
Spezifität der Morpholino antisense Technologie, öffnen die in dieser Arbeit charakterisierten 
und  angewandten Werkzeuge die Tür für eine große Bandbreite an wissenschaftlichen 
Untersuchungen. 
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Chapter I: INTRODUCTION 
Evolving from a single cell, corresponding to the fertilized egg, to complex multicellular 
organisms represented at all times an intriguing part of life. Clearly, several processes that 
lead to the development of the complex structures of the adult body, called embryogenesis, 
involve a plethora of genes. First of all, the egg undergoes a series of cell divisions, known as 
cleavage. Then the pattern formation process gives to the cells an organized activity that can 
define the body plan (e.g. antero-posterior axis) and the germ layers (ectoderm, mesoderm 
and endoderm) with distinct features that will give rise to different tissues. The third 
developmental process, or morphogenesis allows the embryo to change form, mostly during 
gastrulation (outer embryonic cells are internalized). Finally, cell differentiation is 
characterized by the gradual formation of distinct cell types (Wolpert et al. 2006).  
Vertebrate embryonic development depends broadly on diverse proteins differently expressed 
in distinct types of cells and at different time points. This differential expression of genes 
explains the emergence of distinct cell types with the same initial genomic information 
(Gilbert 2010). Particularly during development, the transcriptional regulatory machinery is of 
great importance. Indeed, the key actors of cell fate determination are transcriptional 
regulators (TRs) which activate or repress the transcription of specific genes, thus controlling 
gene expression in a spatial and temporal manner. Among those regulators, transcription 
factors (TFs) act by binding to DNA at specific regions known as gene regulatory elements, 
such as promoters, enhancers or repressors. Specific combinations of TR activities lead to the 
generation of different cell types with distinct functions (Davidson 2010). Moreover, 
transcription is also affected by chromatin structure as it controls the accessibility of the DNA 
binding factors to their specific regions in the genome. Chromatin modifiers are key drivers of 
this process and act in line with the TRs to regulate gene expression (Alberts et al. 2013).  
Although most general principles of development apply to all live multicellular organisms, 
their diversity makes biological investigations highly complex. Therefore, focus was placed 
on a small number of organisms with easy manipulation and ability to use in diverse 
experimental ways: the model organisms. Among them zebrafish, or Danio rerio, is a 
relatively small freshwater fish that is native to rivers in India. This teleost fish can be easily 
maintained in aquariums in large numbers in laboratories. The potential of zebrafish as a 
research tool was highlighted in the 1980 by George Streisinger and colleagues (Streisinger et 
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al, 1981). A vertebrate organism with a number of advantages as an experimental system: a 
large number of offsprings (200-300 eggs per mating) with a short generation time (3-4 
months to get adult fish). An external fertilization and a transparent embryo allowing the 
accessibility of all developmental stages (which some are showed in Figure 1). A fully 
sequenced genome and the possibility to create transgenic and homozygous lines. In addition 
to that, the zebrafish is a vertebrate like humans and is, in opposition to mouse or rat, easier 
and cheaper to handle. During more than 20 years, the zebrafish confirmed its significant 
value as a model for human development and diseases.  
 
 
 
 
 
 
 
 
Figure 1: A schematic representation of the fast development of the zebrafish. Adult zebrafish of 
3 months old lay between 200 and 300 eggs. The zygote period (1-cell) precedes the first cleavage 
that occurs at 0.75 hours (2-cells). The blastula stage is represented with a 256-cell at 2.5 hours and 
the gastrula at 8 hours with a 75% epiboly embryo. During segmentation, the somites are formed (e.g. 
14-somite stage at 16 hours). At 25 hours, the heart is already beating and the larval stage starts after 
72 hours with a protruding mouth. During the larval period, the fish starts swimming and feeding then 
reaches reproductive maturity in 3 months.   
1.1.  Neurogenesis in zebrafish 
One of the most complex organ systems is the nervous system, which contain multiple cell 
types forming a large neural network. The process leading to the generation of mature and 
functional neurons from undifferentiated neural progenitors is named neurogenesis (Detrich et 
al. 2010). In neurogenesis, different steps allow the formation and the maintenance of the 
central nervous system (CNS): induction of neural progenitors, amplification of the progenitor 
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pool by division, specification and determination of cell fate and finally differentiation to 
post-mitotic neurons (Wilson & Edlund 2001). Each of these processes is meticulously 
orchestrated in a spatial and temporal manner, by specific signaling pathways and by the 
expression of different TFs, in order to generate the multiple cell types forming the CNS 
(Bally-Cuif & Hammerschmidt 2003). 
In the zebrafish embryo, the formation of the neural plate at the dorsal part during gastrulation 
represents the first step of neural induction, as the cells of the ectoderm are specified to form 
the neuroectoderm containing neural precursor cells. It has been shown in other organisms 
(frog and chick) that neural induction is triggered by different extrinsic signaling factors: the 
bone morphogenic proteins (BMPs), wingless-integrated (Wnt) and fibroblast growth factor 
(Fgf), plus intrinsic transcription factors, specifically by members of the SoxB1 family 
(Wilson & Edlund 2001; Rogers et al. 2009).  
The neural plate represents the basic outline for the nervous system with rough coordinates 
and subdivisions. Its folding during neurulation gives rise to the neural tube that will form the 
brain anteriorly and the spinal cord posteriorly (Gilbert, 2010). After neural tube formation, 
neuroepithelial cells transform into radial glial cells, which are cells with a cell body in the 
ventricular zone and long radial fibers extending through the neural tube. Radial glial cells 
divide both symmetrically and asymmetrically, in this last case giving rise to one 
differentiating neuron and one radial glial cell, thus maintaining the progenitor pool. The 
Notch signaling pathway was suggested to play a role during this process as high Notch 
activity was observed in the self-renewing daughter cells (Schmidt et al. 2013a).  
At late gastrulation, another process allows the formation of new neurons to occur with the 
maintenance of the progenitor pool. Indeed, at this stage, “proneural genes” are expressed in 
progenitors of the “proneural cluster” which can initiate neurogenesis (Appel & Chitnis 
2002). However, a limited number of the progenitors undergo the exit of the cell cycle and 
differentiation into neurons (Figure 2). Thus, a selection process called “lateral inhibition” 
occurs in which one of the cells of the proneural cluster expressing high level of proneural 
genes will form a neuroblast, while its neighbor-cell down regulates the expression of 
proneural genes and remains as a progenitor (Wolpert et al. 2006). The process of lateral 
inhibition is initiated by the induction of a Notch ligand and its expression in the future 
progenitors, plus the activation of the Notch signaling pathway in the neighboring cells which 
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lead to the expression of repressors that downregulate proneural gene expression (hes genes) 
(Bertrand et al. 2002).   
 
The first expressed proneural genes in zebrafish encode transcription regulators (e.g. the 
bHLH transcription factor neurogenin1). The sequential activation of TFs, in a precise spatial 
and temporal manner, leads to the generation of distinct types of neurons and glia from neural 
progenitors. The induction of the neurogenic cascade and the neural specification is under the 
control of different extracellular signaling pathways that regulate the activity of these diverse 
TFs (Guillemot 2007). Thus, during neurogenesis, the expressed regulators can be used as 
markers to distinguish between the different cell-types that coexist in the CNS.    
Our group undertook a systematic analysis of TR gene expression in zebrafish in order to 
elucidate the transcriptional regulatory networks during the development of the embryonic 
CNS and in the adult telencephalon. First by microarray analysis, a number of TRs are 
profiled at different stages of embryonic development and in some adult body parts. Then, a 
genome-wide analysis of gene expression states were compiled by RNA sequencing 
(RNAseq). 3302 TR genes were detected in the zebrafish genome with possible affiliation to 
the transcriptional machinery. It was observed that most of these TR genes were expressed at 
 
 
 
 
 
 
Figure 2: Regulation of neurogenesis in early development. The expression of proneural genes is 
induced by neurogenic signals and the progenitors accumulating high levels initiate differentiation 
into neurons. Meantime, proneural genes are down-regulated in other neiboughing cells through 
lateral inhibition, thus staying in a progenitor state. Adapted from (Bertrand et al. 2002). 
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24 hours post-fertilization (hpf) as it represents a critical time for neurogenesis and 
organogenesis. By in situ hybridization, an atlas of gene expression for 1711 genes at 24 hpf 
was provided (Armant et al. 2013).  
1.1.1. Neurogenesis in the zebrafish spinal cord 
In order to understand the neural specification and function in vertebrates during 
development, the spinal cord represents a relatively simple model (Figure 3A). Combinations 
of TFs are activated by signaling pathways in a spatial and temporal manner, defining 
different progenitor domains along the dorsal-ventral (DV) axis of the neural tube. Each 
domain generates one or more neuronal subtypes (Dessaud et al. 2008).  
Actually, distinct cell types populate defined domains along the DV axis of the neural tube. 
Floor plate cells are formed in the ventral midline of the spinal cord with three stripes of cells: 
one medial floor plate (MFP) flanked by cells of lateral floor plate (LFP) on both sides 
(Strähle et al. 2004). Several experiments suggested that the main signal inducing 
specification of the LFP in zebrafish is the secreted Sonic hedgehog (Shh) protein. A gradient 
of this morphogen, released by the notochord and the floor plate, controls the specification of 
motorneurons and different subtypes of interneurons in the ventral spinal cord (Appel & Eisen 
1998; Jessell 2000). A combination of TFs from the homeodomain (HD) and basis helix-loop-
helix (bHLH) families are regulated by the Shh signaling pathway and thus define distinct 
progenitor domains that will give rise to different neuronal subtypes (Dessaud et al. 2008) 
(Figure 3B).  
The LFP progenitors generate V3 and Kolmer-Agduhr” (KA”) interneurons under the control 
of the homeobox TFs Nkx2.9, Nkx2.2a and Nkx2.2b. Gata2 and Tal2 are two TFs that 
regulate the specification of the KA”. More dorsally, the motoneuron progenitors expressing 
olig2 give rise to KA’ interneurons, whereas the V2 domain produces V2a and V2b 
interneurons (Yang et al. 2010).  
The p2 progenitor domain from which V2 interneurons are specified is known in mouse to 
also generate a third subtype, V2c interneurons (Panayi et al. 2010). In zebrafish, the p2 
domain indeed gives rise to V2a interneurons, characterized by vsx1 and vsx2 expression, and 
V2b interneurones, characterized by the expression of gata2, gata3, tal1 and tal2. However, 
no clear evidence showed the existence of V2c interneurons in zebrafish. Only few years ago, 
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a study performed in our laboratory by Yang et al. suggested the presence of a new cell 
subtype in the spinal cord and was referred to as V2c interneurons (Yang et al., unpublished 
data). Experiments showed that the specification of V2c interneurons in zebrafish was under 
control of sox1a and sox1b genes, which are detected in the systematic expression screen of 
TRs in a 24 hpf zebrafish embryo and expressed in distinct cells of the ventral spinal cord 
(Armant et al., 2013).  
 
Figure 3: Organization of the spinal cord. (A) Relative position of the brain, spinal cord, 
notochord and floor plate. (B) A schematic representation of a cross section through the ventral 
spinal cord. Shh molecules (blue dots) are released from the floor plate (FP) and the notochord (NC) 
and spread in a gradient manner. The different progenitor domains (p3 to p0) express a combination of 
TF genes regulated by Shh signaling pathway. Distinct neuronal subtypes (V3 to V0) are generated 
from the progenitor domains and express a set of post-mitotic genes that can be used to characterize 
them. Adapted from Rowitch 2004 and England et al. 2011. 
Sox1 a and b are closely related genes that encode TFs, belonging to the SRY-box containing 
genes B1 (SoxB1) family. They contain a homologous sequence of a DNA-binding domain: 
the HMG-box. Both genes are expressed in the GABAergic KA (KA’ and KA”) and in V2 
interneurons in the spinal cord. Functional analysis using morpholino knock-down were 
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previously performed in order to down-regulate the sox1 genes. However, the high shared 
identity of the two genes made it impossible to target sox1 a and sox1b individually (Yang et 
al., unpublished data).  
It was shown that the double knockdown of sox1a/b did not affect the differentiation of the 
KA interneurons subtypes. On the other hand, the knockdown of both genes seems to increase 
the number of cells expressing tal2, gata2, gata3 and gad67, which are markers of V2b 
neurons (Batista et al. 2008), suggesting the increase of this subtype. Nevertheless, the 
expression of V2a neuronal markers did not change (vsx1/2). Taking into account that sox1a/b 
are only partially co-expressed with the markers of V2b subtype, it was suggested that a 
proportion of the sox1a/b expressing cells might differ from V2b and characterize a new 
subtype of V2 interneurons: V2c (Yang et al., unpublished data).   
The study of Yang and colleagues also showed a decrease in the newly identified V2c neurons 
when Sox1a/b protein translation was down-regulated. Indeed, a clear reduction of cells 
expressing sox1a or sox1b mRNA was observed (sox1+/gad67- or sox1b+/gad67-), while V2b 
cells expressing both mRNAs (sox1a+/gad67+ or sox1b+/gad67+) increase. These 
observations suggest that V2b and V2c interneurons derive from the same precursor, and most 
likely, sox1a/b have a role in the specification of V2c cells.   
1.1.2. Neurogenesis in the zebrafish adult brain 
For a long time, the nervous system was considered as incapable of generating new neurons, 
until Joseph Altman suggested the possibility of adult neurogenesis in the mammalian brain, 
more than 50 years ago (Altman 1962). Further studies established that newborn neurons are 
continuously generated in the adult brain from constitutively active progenitor regions. In 
mammals, only two main zones of the telencephalon are known for their neurogenic activity: 
the subventricular zone (SVZ) lining the lateral ventricle, and the subgranular zone (SGZ) of 
the dentate gyrus (DG) in the hippocampus (Reynolds & Weiss, 1992). Unlike mammals, the 
adult brain of teleost fish has a widespread cell proliferation in all subdivisions along the 
rostrocaudal axis with high regenerative capacity. Presently, 16 regions were identified in the 
entire brain of zebrafish with proliferative activity (Grandel et al. 2006; Kaslin et al. 2008). 
Among these areas, the progenitor zones in the telencephalon of the zebrafish are highly 
interesting because of similar aspects in the mammalian brain, making it an excellent model 
system for comparative studies. 
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Proliferation zones have the particularity to harbor stem cell niches formed by different neural 
stem cells that give rise to diverse cell types (Kizil et al. 2011; Merkle & Alvarez-Buylla 
2006). The progenitor cells populating the ventricular zone (VZ) of the zebrafish 
telencephalon express distinct sets of markers that can be used to distinguish and classify the 
different subtypes (März et al. 2010). In the adult zebrafish telencephalon, radial glial cells 
have a critical role in generating new neurons. In contrast, radial glial cells in mammals have 
a role in the embryonic development of the telencephalon but then lose their properties and 
turn into astrocytes (Kizil et al. 2012).  
We will focus in this part of the study on progenitors populating the VZ of the adult zebrafish 
telencephalon, according to the classification that was suggested by März et al. and depicted 
in figure 4. Type I cells are non-dividing radial glia, mainly quiescent, are present in the 
ventral part of the VZ and express glial markers such as Nestin, S100ß, the glial acidic 
fibrillar protein (GFAP) and the brain lipid-binding protein (BLBP). Type II cells represent 
slowly-dividing cells that express, additionally to the previous markers, the proliferating cell 
nuclear antigen (PCNA). These cells constitute the majority of proliferating cells in the 
medial region of the VZ. Type II cells give rise to type III cells (neuroblasts). Type II cells 
can be separated into two groups: Type IIIa cells that express the neuronal and 
oligodendrocyte progenitor marker PSA-NCAM, but still co-express PCNA, Nestin and other 
glial markers, and the type IIIb cells which lack the expression of Nestin and all glial markers. 
All described types of progenitors also express Sox2, which is a stem cell marker (März et al. 
2010; Schmidt et al. 2013b).  
The type II stem cells have the ability to divide symmetrically and asymmetrically to self-
renew and to generate type II cells. The balance between quiescent and proliferating cells has 
to be controlled in the adult brain in order to maintain the stem cell pool. The Notch signaling 
pathways seems to be implicated in this process, similarly to lateral inhibition in the embryo. 
Indeed, the activation of the Notch pathway drives the stem cells into quiescence, while 
blocking Notch restores stem cell division and formation of neurons (Chapouton et al. 2010; 
Rothenaigner et al. 2011). 
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Figure 4: Distinct cell types at the ventricular zone of the adult zebrafish telencephalon with 
different sets of expressed markers. (A) and (B) represent a schematization of the cells on cross-
sections at anterior and medial levels of the telencephalon, respectively. (C) Expression of the 
different radial glia, progenitor and neuroblast markers. Type I and II cells show strong expression of 
radial glia markers, while in Type III cells these markers are low or absent. The regulation of the 
balance between quiescent and proliferating cells by the Notch signaling pathway is represented. 
Modified from (März et al. 2010). 
1.2. Regeneration of the zebrafish adult brain 
The ability to replace lost neurons, due to injury or degenerative diseases, by newly born ones 
has always been of a great interest. However, the ability of neuronal regeneration is highly 
related to adult neurogenesis potential. As mentioned above, this ability in mammals is very 
limited compared to the one of zebrafish. Indeed, studies in teleost fish demonstrated an 
extensive regeneration potential in different organs (e.g. spinal cord, retina) and also in the 
CNS (Becker & Becker 2008).  
In order to understand the regulatory network controlling the regenerative capacity of the 
zebrafish brain, a screen to identify TR genes that play a role in this process was performed in 
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our laboratory. First of all, a stab-injury assay was established (März et al. 2011). A wound is 
generated by inserting a needle through the skull into one telencephalic hemisphere, while the 
opposite hemisphere is kept intact for control. After 5 days post-lesion (dpl), as the maximal 
proliferative time (high expression of PCNA), the brains were prepared and in-depth RNAseq 
was used to assess the expression of genes in both injured and control hemispheres. Focusing 
on misregulated genes with TR features (InterPro protein domain prediction), 279 regulatory 
genes were identified. The majority of these genes are up-regulated after injury and the most 
represented signaling pathways are immune response, apoptosis and Wnt (Viales et al. 2015).  
Additionally, using in situ hybridization, TR genes expressed specifically at the VZ of the 
telencephalon were investigated and 60 of them were shown to be up-regulated upon injury, 
thus suggesting an implication in the regulation of neuronal regeneration. Among them, id1, 
one of the id genes supposed to have a role in maintaining the neural stem cell pool in the 
mouse adult brain (Niola et al. 2012; Jung et al. 2010).  
The DNA-binding protein inhibitor 1, Id1, belongs to a sub-family of helix-loop-helix (HLH) 
proteins that lack the basic DNA binding domain. Thus, by interacting with its partners, 
members of the basic HLH (bHLH) family of transcription factors, it inhibits their DNA 
binding and transcriptional regulation abilities (Norton, 2000). Thus, they act as dominant 
negative regulators for bHLH TFs and play a role in cell proliferation and differentiation 
during development and at adult stage (Wong et al. 2004; Norton 2000; Lasorella et al. 2014). 
For instance, Id proteins bind to the HLH domain of the ubiquitous E proteins (class of bHLH 
TFs), preventing the formation of heterodimers with tissue-specific bHLH factors and by that 
blocking formation of functional transcription complexes. Since it was shown that TFs from 
the bHLH family regulate cell fate determination and differentiation, we can consider that Id 
proteins can control these processes in a variety of tissues (Ruzinova & Benezra 2003; Jung et 
al. 2010).  
The previous study of Viales et al. showed that Id1 is expressed in all the ventricular domains 
of the zebrafish telencephalon, more abundantly in the dorsomedial and the dorsolateral VZ of 
the pallium, except for the rostral migratory stream (RMS) (Figure 5A). The expression of the 
gene is highly up-regulated at 5 dpl (Figure 5B) then decrease gradually at 7 dpl. 
Immunohistochemistry experiments using the stem cell markers S100ß and PCNA indicated 
that id1 is predominantly expressed in quiescent type I cells. Further gain and loss-of-function 
experiments for id1 were performed. Actually, lipofection of an id1 expression construct in 
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the ventricle suggested a role of this regulator in conferring quiescence to radial glial cells 
(lower proportion of PCNA+ proliferating cells). Whereas, the knock-down of id1 by vivo-
morpholino showed an increase in proliferating cells (PCNA+ cells). The obtained results of 
this previous study suggested a specific role of id1 in sustaining the balance between 
quiescence and neurogenesis and maintaining a neural stem cell pool in the adult brain.  
 
Figure 5: In situ hybridization on sections of the adult zebrafish telencephalon. (A) id1 expression 
in the ventricular zone of the adult zebrafish telencephalon. (B) id1 expression shows an upregulation 
(arrows) 5 days after brain injury (left hemisphere) compared to the uninjured control (right 
hemisphere). Adapted from Viales et al. 2015. (C) Expression of the members of the Id family in the 
adult zebrafish telencephalon. Id2a, id3 and id4 are expressed in different part of the adut brain, while 
id2b is not detected. Adapted from Diotel et al. 2015. 
However, the molecular mechanism behind id1 function has still to be clarified in the 
zebrafish telencephalon. Moreover, other members of the Id protein family can be involved. 
In the mouse, it was shown that a conditional triple knockout of id1, id2 and id3 lead to the 
loss of stemness of NSCs that undergo premature differentiation and to their detachment of 
the stem cell niches. Thus, suggesting a role of Id proteins in synchronizing stemness and 
anchorage of NSCs (Niola et al. 2012). In zebrafish, four other id genes have been identified 
in addition to id1: id2a, id2b, id3 and id4. It was already shown in the zebrafish embryo that 
the id genes have partially overlapping expression patterns. However, the expression of these 
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genes in the adult zebrafish telencephalon was just recently documented. Indeed, our 
colleagues Diotel et al. showed, by in situ hybridization, a wide expression of the id genes in 
the entire adult brain of zebrafish, except for id2b that was barely detectable (Figure 5C) 
(Diotel, Beil, et al. 2015). Whether other members of the Id family contribute to the regulation 
of neurogenesis in the adult brain has still to be clarified.  
1.3. Reverse genetic technologies in zebrafish 
Using forward genetics, meaning to go from the phenotype to the gene, large scale mutational 
screens were performed in zebrafish and provided a lot of understanding of vertebrate 
development (Tübingen and Boston screens, Nüsslein-Volhard 2012). On the other hand, 
reverse genetic tools would provide mutations in any genes of interest to evaluate its 
functions, but they were for a long time unavailable for zebrafish studies. This state has 
changed already with the development of strategies for loss-of-function studies, such as 
mutagenesis screens (e.g. TILLING), or the antisense morpholino oligonucleotides. 
Additionally, in the last few years, engineered endonucleases have emerged and enable to 
achieve directed genome modifications in zebrafish (Figure 6) (Huang et al. 2012).  
 
Figure 6: Chronoligical evolution of reverse genetic approaches used in zebrafish starting from a 
terget gene. ENU, N-ethyl-N-nitrosourea; TILLING, Targeting Induced Local Lesions IN Genomes; 
ZFN, zinc finger nuclease; TALEN, transcription activator-like effector nuclease; CRISPR, clustered 
regularly interspaced short palindromic repeats.  
In reverse genetics, the first main goal is to select a specific gene in order to modify it or its 
expression and to investigate its function. The used approaches for reverse genetics can be 
non-targeted (e.g. TILLING) or targeted (e.g. site-specific nucleases) (Tierney & Lamour 
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2005). With the fully sequenced genome of zebrafish, many novel and functional genes were 
identified by bioinformatics analysis or through screening by in situ hybridization for tissue-
specific gene expression (Huang et al. 2012).  
1.3.1. Morpholinos knockdown 
For a long time, morpholino oligonucleotides (MOs) were the most used knockdown tools in 
zebrafish even though, strictly speaking, they do not represent a proper reverse genetic 
approach as they do not disrupt the genetic information itself. Morpholino antisense oligomers 
were developed in 1997 as a method to inhibit RNA translation in vivo (Summerton et al. 
1997). MOs, shown in figure 7A, are chemically modified oligonucleotides of commonly 25 
nucleic acid bases bound to morpholine rings (instead of ribose or desoxyribose) and linked to 
uncharged phosphorodiamidate groups (in place of the phosphodiester groups) (Summerton & 
Weller 1997). MOs are resistant to nucleases and can bind via base-pairing to mRNAs with 
high affinity and prevent their translation via steric interference (Figure 7B). The translational 
blocking is the consequence of MO binding to the 5’ untranslated region (UTR) which 
obstructs the initiation complex of translation (Sumanas & Larson 2002). MOs can also 
interfere with the splicing process by blocking sites involved in the pre-mRNA processing, 
leading to the expression of altered transcripts; premature stops and non-sense-mediated 
decay (Draper et al. 2001). The splicing blocking can be used for gene knock down, but also 
to study the function of mRNA isoforms resulting from alternative splicing. 
In zebrafish, MOs are usually injected in early embryos (1-8 cell-stage) to achieve ubiquitous 
delivery (Bill et al. 2009). The MO-injected embryos are named “morphants”. Hundreds of 
genes were targeted in this manner and distinct phenotypes were observed. However, this 
approach has several limitations: the limited time of MO effect as the embryonic development 
lead to their dilution (up to 5 dpf). The non heritable genome modifications restrain the use of 
MOs to transient studies. The occurrence of off-target effects which complicate the evaluation 
of specific impacts. It has been shown that MOs activate the p53 pathway, leading to cell 
death and embryonic defects in a non-specific manner (Robu et al. 2007). Therefore, control 
experiments are essential in order to draw proper conclusions using MO gene knock down. 
For instance, the use of control MOs with several mismatches (5 nt mismatches) which should 
have no activity, rescue experiments by co-injecting mRNA coding for the target protein, 
several MOs targeting the same gene should have similar phenotypes, and injecting a p53 MO 
or using a p53 mutant in order to avoid unspecific effects (Eisen & Smith 2008).  
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Figure 7: Morpholino anti-sense. (A) Schematic representation of morpholino oligonucleotide 
structure compared to the DNA. The desoxyriboses is replaced by morpholine rings, while the anionic 
phosphodiester linker is replaced by a non-ionic phosphorodiamidate group. Adapted from Corey & 
Abrams 2001 (B) The mode of action of MOs. The translation blocking MO targeting the 5’ UTR 
region prevent translation by blocking the small ribosomal subunit of the initiation complex. The 
splice inhibiting MOs interfere with important sites of the splicing process of the pre-mRNA giving 
rise to truncated transcripts. Adapted from Hardy et al. 2010. 
Furthermore, very recent studies raised a subject of preoccupation concerning the specificity 
of MO knock-down. In fact, comparative analyses between morphants and corresponding 
mutants (obtained with site-specific nucleases) showed discrepancies in 80% of the cases 
(Kok et al. 2014). A large number of morphant phenotypes could be due to off-target effects 
of the MOs, according to the authors and to other scientists working on the zebrafish model 
(Stainier et al. 2015). Indeed, in the study of Kok et al., as an example, they could recapitulate 
an established morphant phenotype (for the long non-coding RNA megamind) even though 
the embryos lacked the target site of the MO, while the corresponding mutant did not show 
any resembling phenotype. The conclusion of these worrisome observations is that the MO 
technology cannot lead to definitive assertions concerning gene function in zebrafish or other 
models. 
To overcome these issues, the suggestion was made to use, more broadly, proper genetic 
approaches to generate mutants, such as site-specific nuclease technologies that are displayed 
below. 
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1.3.2. Targeting Induced Local Lesions in Genomes 
Targeting Induced Local Lesions in Genomes, or TILLING, is a mutagenesis screening 
strategy used to identify mutations in a gene of interest from a population of chemically 
mutagenized fish (Stemple 2004). The mutagen N-ethyl-N-nitrosourea or ENU, used in 
zebrafish, introduces point mutations in the genome. Sample DNAs of individuals from the 
library of mutagenized fish are used as a template for screening. After PCR amplification of 
specific regions of the gene of interest, usually the exons, the products are melted and re-
annealed. If a point mutation is present, a heteroduplex will be formed and recognized by the 
endonuclease Cel-I which cleaves and generates smaller fragments. The detection of 
mutations is then done by gel electrophoresis and the potentially mutated fragments are 
subjected to sequencing for confirmation (Fish Physiology: Zebrafish, 1st Edition, 2010). 
Another approach for detection of the mutations is by direct sequencing of the amplified 
fragment. Large-scale screenings for point mutations were facilitated by the development of 
next-generation sequencing and whole exome enrichment technologies (Huang et al., 2012).  
The large mutant libraries and the large sequencing capacities required to identify a specific 
mutation in a gene of interest make the TILLING strategy labor-intensive and hard to 
accomplish in any laboratory. To counter this, a zebrafish mutation project by TILLING has 
been organized by the Sanger Institute in order to enable researchers to obtain required 
information about their genes of interest (http://www.sanger.ac.uk/Projects/D_rerio/zmp/).  
1.3.3. Zinc-Finger Nucleases  
Despite the broad use of the approaches cited above to study the function of important genes 
in zebrafish, the limit in this model was still the site-specific genome modification for gene 
targeting, which was restricted for a long time to the mouse model (available embryonic stem 
cell lines). In 2008, this has changed with two publications that demonstrated the effective 
generation of targeted mutations in zebrafish by using Zinc-Finger Nucleases, or ZFNs 
(Doyon et al. 2008; Meng et al. 2008).  
ZFNs are chimeric proteins consisting of a zinc-finger DNA-binding domains fused to the 
catalytic domain of the endonuclease FokI (Kim et al. 1996). The type C2H2 zinc-finger 
protein used to create the ZFN comprises 30 amino acids and is characterized by a zinc ion 
coordinated by two cystein residues in two anti-parallel β- sheets and two histidine residues in 
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an α-helix. It binds to a specific DNA sequence of 3 bp via its alpha helix domain (Ochiai & 
Yamamoto 2015). 
 
Figure 8: Schematic representation of the zinc finger nucleases (ZFNs). Two opposing zinc-finger 
binding sites recognize a specific sequence of the DNA. Each finger binds to a DNA triplet. The 
binding site is fused to the catalytic domain of the endonuclease FokI, which dimerize in order to 
create double-strand-breaks (DSBs) in the DNA. DSBs are repaired via the error-prone pathway: Non-
homologous end-joining (NHEJ) in which the DNA is altered by insertions or deletions (indels), or via 
Homology repair using a template DNA.  
Typically, the DNA-binding domain of a ZFN contains three zinc-finger motifs recognizing a 
sequence of 9 bp. Furthermore, since the non-specific FokI cleavage domain is active as a 
dimer, an opposing pair of ZFN is needed to cleave a DNA target sequence, in the spacer 
region of about 6 bp, between the two binding domains (Bitinaite et al. 1998; Huang et al. 
2012). Consequently, double-strand breaks (DSBs) are generated into the DNA and have to be 
repaired otherwise lethal. The DSBs are repaired by two naturally occurring mechanisms: 
Non-Homologous End-Joining (NHEJ) or Homologous Recombination (HR). In NHEJ repair, 
the break ends are directly joined with the introduction of small insertions or deletions 
(indels) that can alter the genomic sequence as it is an error-prone repair pathway. On the 
other hand, the HR can be used to edit a gene as it is based on the replacement of the DNA 
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break using a repair template, either a genomic one or a supplied one in a form of a single 
strand oligonucleotide (Carroll 2014) (Figure 8).  
In zebrafish, the work of two groups, Doyen et al. and Meng et al. showed the efficiency of 
ZFN to generate target-specific mutations in this model organism. Using proof-of-principle 
genes with well known phenotypes, both demonstrated the disruption of these loci in a 
specific manner by NHEJ repair pathway (Doyon et al. 2008; Meng et al. 2008). Since then, 
ZFNs as a first genome targeting method in the zebrafish have been used to generate 
mutations in a large number of genes. Indeed, these customizable proteins can be designed to 
target any DNA sequence of interest. Several methods are used to design ZFNs, including the 
modular assembly (MA) which makes use of the direct ligation of preselected zinc-finger 
modules recognizing DNA triplets and collected in libraries (Amacher 2008). However, the 
zinc-finger proteins designed with this method showed high failure rates because of the 
context dependency of zinc-fingers (for other zinc-fingers and for the DNA) (Ramirez et al. 
2008). To counter this difficulty, methods to select individual fingers with well-validated in 
vivo activity have been developed. The Oligomerized Pool Engineering (OPEN) method uses 
the bacterial two-hybrid system to identify new modules from randomized libraries, in a 
context-dependant manner (Maeder et al. 2008). The Context-Dependant Assembly (CoDA) 
combines both cited methods to ligate characterized context-dependant zinc-finger modules, 
already archived, by modular assembly (Sander, Dahlborg, et al. 2011). Also, in order for 
researchers to avoid the relatively laborious and time consuming construction of zinc-finger 
proteins, commercially available ZFNs, even though pricey, can be acquired from Sangamo 
Boscience (CompoZr ZFNs, Sigma-Aldrich).  
ZFNs are an effective tool to generate targeted mutations, however, the synthesis of ZFNs 
with high specificity to the target is expensive, labor intensive and time consuming. 
Moreover, recently the development of alternative technologies such as transcription 
activator-like effector nucleases (TALENs) and CRISPR (Clustered regularly interspaced 
short sequences)/Cas (CRISPR-associated) have emerged as faster and cheaper alternatives. 
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1.3.4. Transcription Activator-Like Effectors Nucleases 
1.3.4.1. Transcription Activator-Like Effectors origins 
Transcription Activator-Like (TAL) effectors represent a large family of type-III effectors, 
predominantly found in Xanthomonas, a gram negative bacterial plant pathogen (Boch & 
Bonas 2010). Type-III denomination comes from the type of protein secretion system used by 
these effectors. The type-III secretion system is essential for Xanthomonas pathogenicity. 
Indeed, it separates the bacterial membranes and a so called “needle complex” penetrates the 
host plant cell (Galán & Wolf-Watz 2006). The bacterial proteins are then directly secreted 
into the host cytoplasm. Different plant pathways are targeted in order to suppress the plant 
defense and to facilitate the bacterial virulence (Figure 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Representation of TAL effector functions in a plant cell. The TALE is secreted by a 
bacterial plant pathogen via the needle complex of the type III secretion system. The TALE 
translocates into the nucleus where it binds to the DNA and activate the transcription of host genes to 
facilitate spread and colonization. 
The first member of this family to be isolated from the pepper and tomato pathogen 
Xanthomonas campestris was the avrBs3 gene. The DNA sequence analysis (by deletion 
analysis) of this gene showed a number of direct-repeats present 17.5 times, each one 
consisting of 34 amino acids (aa) (Bonas et al. 1989). The last repeat of AvrBs3 is only 
similar to the other repeats in its first 20 aa and was therefore called “half-repeat”. Several 
homologs were discovered from other Xanthomonas species, and strikingly with highly 
conserved tendem-repeats. The difference lied on the number, the order and the length of the 
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repeats. Comparison of the repeats uncovered hypervariable residues at the position 12 and 13 
(Hopkins et al. n.d.).  
The AvrBs3 family effectors contain a N-terminal region required for the type III secretion, 
an essential nuclear-localisation signal (NLS) and an acidic activation domain (AD) at the C-
terminal region (Figure 10A) (Bogdanove et al. 2010). These motifs were also shown to be 
conserved in the avrBs3 homologs.  
 
Figure 10: TAL effector organization and structure. (A) The TALE contains a translocation 
domain (green) at the N-terminal region. The central region consists of the repeat domain (red) which 
binds DNA, preceded by a thymine at position 0. A NLS (yellow) permits nuclear transport and a 
transactivation domain AD (blue) which activates transcription at the C-terminal region. (B) A closer 
view into one repeat which contains 34 amino acids with a variable di-residue (RVD) at position 12 
and 13, having one-to-one correspondence to a single nucleotide (red text box). (C) Structural 
representation of the TALE repeats. From left to right, one repeat harboring the RVD, a TAL effector 
of 11.5 repeats and its interaction with DNA. The structure representation is adapted from Deng et al. 
2012.  
The functionality of the AD domain of TAL effectors was first shown in the protein of the 
rice pathogen Xanthomonas oryzae, but the activity of TALEs as transcription factors was 
revealed with AvrBs3 and its targets named UPA (upregulated by AvrBs3). Indeed, this TAL 
effector directly binds to an UPA box (a conserved promoter element) to activate the 
transcription of the UPA genes which will facilitate the colonization and spread of the 
pathogen (Bogdanove et al. 2010).  
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The specificity of TAL effectors was already shown more than ten years ago to be determined 
by its repeat domain (Herbers et al. 1992). Several years later, another discovery increased 
interest in TAL effectors, the capacity of AvrBs3 to interact directly with DNA (Römer et al. 
2007; Kay et al. 2007). This novel DNA-binding domain was further studied in order to 
identify the base pair recognition specificities. In 2009, two different studies cracked indeed 
the code of the DNA binding specificity of TAL effectors (Moscou & Bogdanove 2009; Boch 
et al. 2009).  
Moscou and Bogdanove solved the cipher in silico by alignment of known TAL effector 
target promoter sequences and the hypervariable residues, named repeat-variable diresidue 
(RVD), with minimal entropy.  The consistence of RVD-nucleotide associations seems to 
concord to a one-to-one correspondence between an RVD and a nucleotide in the target site of 
TAL effectors (Figure 10B). This cipher, partially degenerate, has no evident context 
dependence, except for a strictly conserved T at position zero (Moscou & Bogdanove 2009). 
Boch et al. used the UPA box on which AvrBs3 directly binds to investigate the specificity of 
the TAL effector binding. The size of the UPA box corresponds roughly to the number of 
repeats in AvrBs3. It was observed indeed that the RVD of each repeat projected onto the 
UPA box correlates with a single nucleotide in the target DNA. To confirm this model of 
recognition, DNA target sequences were predicted for three different TAL effectors (Hax2, 
Hax3, Hax4) using a GUS assay (β-glucuronidase). The promoter boxes were cloned into a 
vector driven by a minimal promoter (tomato Bs4) and in front of the β-glucoronidase 
reporter gene. After co-transfection with the effectors driven by the cauliflower mosaic virus 
35S-promoter (CMV), the induction of only the corresponding promoters was observed. Also 
in this study, a conserved T at the 5’ end of the target site was noticed and its importance was 
demonstrated (Boch et al. 2009). 
These two studies represent a breakthrough in gene targeting with breaking a simple code that 
can be used to predict the DNA targets of TAL effectors, but also and mostly to generate 
DNA binding domains targeting any DNA sequence. Both works identified the TAL effector 
recognition specificity as follow: HD = C; NG = T; NI = A; NN = A or G; NS = A, C, G or T 
(single-letter codes for the amino acids 12 and 13). 
Structural bases of the TAL effector organization and the TAL-DNA interaction were 
uncovered in 2012 by two studies: one based on a naturally occurring TAL of 23.5 repeats 
21 
 
from the rice pathogen Xanthomonas oryzae (Mak et al. 2012), and the second on an 
engineered TAL dHax3 of 11.5 repeats (Deng et al. 2012) (Figure 10C). Both studies reached 
the conclusions that the repeats are connected with each other and form a right-handed 
superhelix that surrounds the major groove of DNA. The two RVDs are exposed to DNA and 
just the second residue at position 13 interacts specifically with a nucleotide in the DNA, 
while the other residue 12 stabilizes the interaction between the protein and the DNA.  
The modular DNA-binding domain of TAL effectors quickly attracted attention for 
biotechnology. Like zink-finger domains, the TALE DNA-binding specificities can be used to 
design molecules which recognize any target DNA sequence and fused to nucleases, activator 
domains or repressor domains, can generate highly specific tools to manipulate gene 
expression.  
1.3.4.2. TAL Effector Nucleases design and assembly – different approaches 
Similar in a certain way to zinc-finger domains, because of their natural and modular binding 
specificities, TAL effectors were perfect candidates for genome engineering. Thus, TAL 
Effector Nucleases (TALENs), like Zink-Finger Nucleases (ZFNs) in the past, were created 
by fusing the TALE DNA-binding domain to the non-specific catalytic domain of the 
endonuclease FokI (Christian et al. 2010) (Li et al. 2011) (Miller et al. 2011). Unlike ZFNs 
that recognize nucleotide triplets in the DNA, TALENs have the capacity to recognize single 
nucleotides. This feature makes TALENs more specific and more flexible than ZFNs. The 
fusion with FokI permits the use of TALENs for targeted gene modification. Indeed, the FokI 
domain, in its active dimerized form, cleaves both strands of DNA and creates double-strand 
breaks (DSBs) in the genome. This DNA damage can be then repaired via either the error-
prone non-homologous end-joining (NHEJ) machinery, which results in small insertions or 
deletions (indels) that can lead to a frameshift or to the introduction of a premature stop 
codon, or via homologous recombination (HR) or homology-directed repair (HDR), in the 
presence of a DNA sequence used as a donor (Figure 11). 
With the enthusiasm that grew in the last few years for the TALEN technology, different 
methods have been established to design and create/construct an effector against a specific 
DNA target sequence.  
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Figure 11: A schematic representation of TAL effector fusion with the catalytic domain of the 
endonuclease FokI (TALEN). The short distance between opposite positioned TALENs allows the 
dimerization of FokI catalytic domains (red and green) which then activates the cleavage of the DNA 
in both sides, creating double-strand breaks (DSB). DSBs are repaired via error-prone repair with the 
non-homologous end-joining machinery (NHEJ) which leads to insertions or deletions in the target 
DNA, or via homology repair when a template DNA is available. 
The first step to get a working TAL effector binding site is to design a repeat array which 
recognizes the desired target sequence. To that purpose, several tools have been developed 
and are available online or as downloadable softwares. The study of Cermack et al. provided 
with the first online tool for TALEN-targeting design (TAL Effector Nucleotide Targeter, 
TALENT; https://tale-nt.cac.cornell.edu/) , based on guidelines inspired by the natural 
occurring effectors, such as the presence of a T upstream of the TALEN binding site for 
which the length is comprised between 15 and 20 bases. As FokI acts as a dimer, a pair of 
binding sites is needed and the spacer region between the opposing domains, in which the 
cleavage will take place, would have a size of 15 to 30 bp (Doyle et al. 2012). In the 
following years, this tool and other ones with similar criteria have been optimized and 
harbored additional options. The Target Finder, part of the TALENT suite, allows the 
identification of the best scoring site with less off-target activity. Like Mojo Hand ( 
http://talendesign.org/, (Neff et al. 2013)), CHOPCHOP 
(https://chopchop.rc.fas.harvard.edu/index.php (Montague et al. 2014a)) or other web-based 
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tools, prediction of off-targets is included, as well as selection of the RVD targeting Guanine. 
In fact, the RVD NN, previously mentioned, recognizes G but also A. Another RVD targeting 
exclusively G was brought into light recently/subsequently, NH. But it was shown in a study 
that using NH instead of NN increases the specificity for G but lowers the activity of the 
overall TALEN (Streubel et al. 2012).  
From cut-ligation to bead-dependant, whether it is manual or high-throughput, many 
strategies have emerged in order to construct TALENs. The first successful assembly of 
custom TAL effector nucleases was shown by Christian et al. in 2010. The modular assembly 
was the first way used to construct de novo TALENs (Morbitzer et al. 2011; Cermak et al. 
2011). The most accomplished method at the time was well described by Cermack et al. and 
uses the Golden Gate cloning, allowing multiple DNA fragments to be cut and ligated in an 
ordered manner and in a single reaction. Indeed, it is based on the ability of type IIS 
restriction endonucleases to cleave outside their recognition sites and to create unique 4 bp 
overhangs which can be ligated in an ordered fashion as it eliminates the original restriction 
site (Engler et al. 2009).  
Other cut-ligation methods have emerged: Zhang lab used the same basic Golden Gate 
method but replacing the overnight bacterial culture by PCR amplification, which make the 
construction time shorter (3 days compared to 5 days for the normal Golden Gate assembly). 
Hierarchical digestion/ligation strategies, like the “unit assembly” which relies on 
isocaudomer; restriction enzymes with different recognition sites but generate identical ends 
upon cleavage (Huang et al. 2011a), or the restriction enzyme and ligation (REAL) method 
that uses both type I and type II restriction enzymes for series of cut-ligation steps (D Reyon 
et al. 2012). Besides, a ligation-independent cloning method (LIC) was reported, based on a 
library of DNA fragments which anneal to each other via long ssDNA overhangs (10-30 bp) 
(Schmid-Burgk et al. 2013).  
Naturally, high-throughput and automated methods to construct TALENs have emerged. The 
fast ligation-based automatable solid-phase high-throughput (FLASH) method, as the first 
large-scale method for TALEN assembly, relies on a library of one, two, three or four TALE 
repeats in different possible combinations of RVDs. It uses solid-phase magnetic beads, 
allowing automation of the different steps of digestion, purification and ligation of the 
diverse/various repeat fragments that will be assembled in an iterative manner. This method 
permits the simultaneous construction of up to 96 different TALENs in a 96-well plate 
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(Deepak Reyon et al. 2012). The iterative cap assembly (ICA), similarly to the FLASH 
method, uses solid-state beads on which, this time, DNA repeat monomers are assembled 
sequentially. Another property of this method is the use of capping oligonucleotides (short 
hairpins) to inactivate incomplete constructed chains. ICA has the advantage of being 
applicable to microarray printing technology in order to construct a large amount of TALENs 
in a short time (Briggs et al. 2012). 
Depending on the need, on the capability and on the TAL scaffold to be used, TALENs can be 
constructed with any of these methods. For our part, the Golden Gate assembly was a suitable 
method at the time because of its simplicity and its availability.  
1.3.5. Clustered Regularly Interspaced Short Palindromic Repeats 
1.3.5.1. A bacterial immune system 
Bacteria and archaea had evolved their protection against invaders, such as bacteriophages or 
plasmids, to the point of benefiting from a complex and effective adaptive and heritable 
immune system. In 1987, Ishino and colleagues observed an unusual structure while 
analyzing a DNA fragment of Escherichia coli from the K12 strain. Direct repeats arranged 
with 29 nt homologous sequences, separated by 32 nt spacer regions (Ishino et al., 1987). At 
the time, the biological relevance of these first observed sequences was not known but they 
were recognized few years later as a family of repetitive DNA regions particular to 
prokaryotes (Mojica et al. 2000). In the early 2000s, with the expansion of genomic studies, 
the Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR, were 
characterized in silico (Jansen et al. 2002). The CRISPR elements were shown to comprise 
the CRISPR locus which consists of an array of short nearly identical direct repeats separated 
by polymorphic sequences, or spacers, and a set of CRISPR-associated (cas) genes (Jansen et 
al. 2002).  
In 2005, three groups simultaneously reported homologies between the polymorphic 
sequences of the CRISPR loci and DNA sequences of viruses or plasmids (Bolotin et al. 
2005; Mojica et al. 2005; Pourcel et al. 2005). It is known now that the spacers are actually 
derived from foreign DNA invading bacteria and that they are incorporated to the genome to 
provide a memory in order to resist against the same invaders (Barrangou et al. 2007).  
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There are three types of CRISPR systems according to a unified classification following 
multiple criteria (Makarova et al. 2011). The simplest and well studied system is the type II 
from Streptococcus thermophilus which uses the Cas9 endonuclease in its defense against 
bacteriophages and plasmids. The process of this immune system is built on three different 
steps (Bhaya et al. 2011) (Figure 12):  
 
Figure 12: Schematic representation of the CRISPR type II immune system. Acquisition: the first 
step in which the hypervariable spacer containing the PAM (colored triangle) is integrated between 
direct repeats (black rectangle) within the CRISPR array preceded by the leader sequence. The Cas 
locus in the vicinity contains the genes encoding Cas proteins. Expression: the CRISPR array is 
transcribed and processed into CRISPR RNAs (crRNAs) containing the spacer region, with the help of 
the Cas proteins (Cas1, Cas2). Interference: during invasion of a plasmid DNA, the crRNA 
recognizes and binds to the complementary sequence of the spacer and the recruited Cas9 cleaves the 
target DNA and creates double strand breaks (DSB). 
1) The spacer acquisition is the first to happen, in which the spacers are integrated in 
between the repeats and at the leader region. The acquisition of the spacer requires a 
recognition motif which is at the end of the sequence, named protospacer adjacent 
motif (PAM). The proteins Cas1 and Cas2 which are involved in this stage are 
expressed from the Cas locus located in the neighboring of the CRISPR array; 
2) Second, expression from the CRISPR locus. Pre-CRISPR RNAs (pre-crRNAs) 
(primary transcripts) are transcribed and processed/cleaved into small CRISPR RNAs 
(crRNAs) or the guide RNAs. This step requires a trans-activating small CRISPR 
RNA (tracrRNA) which forms a duplex with the CRISPR repeats; 
26 
 
3) The final interference step requires the crRNA to recognize and to bind the 
complementary sequence of a foreign DNA, providing a memory of past invaders. 
Thus, the cleavage of this complex is initiated by Cas proteins.  
During the studies of the CRISPR system, the important parts that allow the interference to be 
achieved were identified: the leader sequence next to the CRISPR array for the acquisition of 
new spacers (Karginov & Hannon 2010). The complex tracrRNA-crRNA which recognizes 
the target DNA sequence (Bhaya et al. 2011). The trinucleotide NGG motif PAM that is 
present at the proximal end of the target which is important for the recognition and for the 
recruitment of the endonuclease Cas9, avoiding then self-targeting (Sternberg et al. 2014). It 
was also shown that the cleavage activity of Cas9 depends on a perfect complementarity of a 
12 bp “seed region” which is proximal to the PAM in the sequence of the guide RNA, 
whereas mismatches in the 8 bp most distant from the PAM are tolerated (up to 6) (Jinek et al. 
2012).  
 
Figure 13: Structure of the Cas9 endonuclease.  Representation of the structure of the Cas9 with its 
two lobes (grey and blue on the left) which change conformation upon interaction with the 
crRNA:tracrRNA (middle) and reorient to form a central channel to bind the target DNA (right). 
Adapted from Jinek et al. 2014. 
Cas9 is a multi-functional protein organized in two lobes: an α-helical recognition lobe which 
binds the gRNA and the DNA and a nuclease lobe (Figure 13). The nuclease lobe contains 
two domains: HNH-nuclease domain which cleaves the target DNA strand, and RuvC-like 
nuclease domain which cut the non-target strand (Jinek et al. 2014a). The interaction with the 
PAM is governed by the carboxyl-terminal domain of the nuclease lobe (Nishimasu et al. 
2014). The architecture of Cas9 protein, that is autoinhibited in absence of interactions with 
nucleic acids, undergoes a conformational change, leading to an active conformation, after 
binding to the guide RNA and the target DNA (Jinek et al. 2014; Jiang & Doudna 2015).  
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1.3.5.2. Programmable targeting with small RNAs 
With the properties of the CRISPR system in mind, numerous investigations were performed 
in order to use this relatively easy procedure for gene targeting (Figure 14). A synthetic 
chimera of tracrRNA-crRNA was created as a single guide RNA (sgRNA) to simplify the 
targeting (Jinek et al. 2012) and different variants of Cas9 proteins were used in several model 
organisms: wild-type Cas9 that cleaves dsDNA causing DSBs, which will be repaired vie 
NHEJ repair or HR if a template is available (Mali et al. 2013a; Hwang et al. 2013; Yasue et 
al. 2014); a mutated Cas9, the Cas9 nickase (Cas9n) that introduces site specific single-strand 
nicks (Cong et al. 2013; Ran et al. 2013); and a catalytically inactive Cas9, the dead Cas9 
(dCas9) that can be fused to various domains, for instance transcriptional activators or 
repressors (Gilbert et al. 2013; Maeder et al. 2013). 
The CRISPR/Cas9 technology opened the door for wide range applications: genome editing, 
transcriptional control, DNA labeling. And all these possibilities are facilitated by the easy 
use and do-it-yourself features of this method. In addition, the targeting efficiency of the 
CRISPR system can be favorably compared to other methods such as ZFNs and TALENs. 
It is preferable to target near the N-terminus of the coding region of a gene because a resulting 
frameshift is more likely to create a null allele the more upstream it is. Several online tools to 
design the gRNAs are available, with more or less the same criteria. The most important 
signature is indeed the presence of the PAM motif (NGG) at the direct vicinity of the target 
sequence. The 5’ end of the gRNA may require specific dinucleotides depending on the 
polymerase used for the RNA synthesis. For example, in our case, 5’GG- is required for the 
T7 polymerase. Determination of off-targets became rapidly a common goal for most of the 
tools. Indeed, the Cas9 endonuclease can tolerate up to 5 base mismatches if adjacent to the 
PAM sequence and also a single base variation in the PAM itself. Among the available tools, 
ZiFiT Targeter version 4.2 (http://zifit.partners.org/ZiFiT/Disclaimer.aspx), an updated 
version from the Zinc Finger Consortium was mostly used. A target is identified from a query 
sequence and the criterion according to the selected promoter can be added (Sander et al. 
2007). The output is given in the form of two oligonucleotides which can be annealed and 
cloned into an expression vector. Another web-based tool, CHOPCHOP 
(https://chopchop.rc.fas.harvard.edu/index.php) can be used to identify gRNA targets from 
species-specific gene IDs (Montague et al. 2014b). 
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Figure 14: A schematic representation of the CRISPR system. The single guide RNA (sgRNA) 
targets a sequence of the DNA containing a protospacer adjacent motif (PAM), required for target 
recognition, and recruits the Cas9 endonuclease that cleaves both strands. DSBs are subsequently 
generated and repaired via error-prone repair (NHEJ), creating insertions or deletions in the target 
DNA (indels), or via homology repair using a template DNA. 
A number of Cas9 proteins were published from different groups to work in zebrafish. Most 
of them derive from Streptococcus pyogenes, either codon optimized for zebrafish or 
synthetically produced (Hwang et al. 2013; Jao et al. 2013a; Ablain et al. 2015). 
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Aim  
A better understanding of the molecular mechanisms involved in embryonic and adult 
neurogenesis is necessary to open the door for new alternatives against neurodegenerative 
diseases, such as Alzheimer’s or Parkinson’s diseases. The main characters of these 
mechanisms are TFs, proteins that regulate gene expression by binding to promoter or 
enhancer regions of the DNA. This transcriptional control plays an important role in 
formation and differentiation of functional neurons. In order to better understand the 
molecular networks controlling the processes of neurogenesis and regeneration of the brain, 
the zebrafish CNS is used as a model for its easy handling and comparable neuronal 
mechanisms to other vertebrates comprising mammals/humans.  
The tools to target specific genes in the zebrafish genome were greatly optimized in the last 
few years. Thus, in this study, the two newly developed methods, TALENs and CRISPR, 
were used in order to perform loss-of-function studies to determine the role of interesting TR 
genes and their molecular mechanisms controlling neurogenesis and adult brain regeneration, 
in two model systems, namely the embryonic spinal cord and the adult telencephalon.  
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Chapter II: MATERIAL AND METHODS 
 
2.1. Equipment and materials 
Bacteria incubators  Heraeus, Hanau, Germany 
Cellstar cellculture dish Greiner, Nürtingen, Germany 
Cool centrifuge J2-HS  Beckman, Stuttgart, Germany 
Cryostatic vial Eppendorf, Hamburg, Germany 
Dissection forceps Fine Tip No.5 (Dumont) 
Eppendorf microcentrifuge tubes  Eppendorf, Hamburg, Germany 
Falkon tubes  Greiner, Nürtingen, Germany 
FemtoJet microinjector Eppendorf, Hamburg, Germany 
Flaming-Brown Needle puller Sutter Instruments, USA 
Gas microinjector Tritech research inc., L.A., USA 
Glass needle 
1.0 mm outer diameter, 0.58 mm inner 
diameter, with filament (TW100, WPI 
Inc.) 
Incubator for fish embryos  Heraeus, Hanau, Germany 
LED pannels 660 / 740 Roither , Switzerland 
Magnetic  thermomixer Heidolph, Rosenfeld, Germany 
Microcentrifuge 5417 R and C  Eppendorf, Hamburg, Germany 
Microcentrifuge Biofuge pico Heraeus, Hanau, Germany 
Microfiltration columns  Pall, Ann Arbor, USA 
Microloader tips  Eppendorf, Hamburg, Germany 
Microscopes 
Leica DMI6000 SD 
Stereomicroscope SMZ645 
Fluorescent stereomicroscopeMZ FLI- II  
Multitank recirculation system Schwarz Ltd, Germany 
NanoDrop ND-1000  Peqlab, Erlangen, Germany 
Omnifix
®
-F 0.01-1ml Syringe Braun, Melsungen AG, Germany 
PCR-Thermocycler 
Biozym Scientific GmbH, 
HessischOldendorf, Germany 
Petri dishes  Greiner, Nürtingen, Germany 
Pipette tips  Corning, Corning, UK 
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Rotilabo
® 
-syringe filters 0.22 µm Roth, Karlsruhe, Germany 
Spectrophotometer  Eppendorf, Hamburg, Germany 
Spin-X-Filter  Costar, Corning, USA 
Sterile filters  Renner, Darmstadt, Germany 
Thermomixer Eppendorf, Hamburg, Germany 
TOP seal A  Perkin Elmer, Massachusetts, USA 
Vortex  Bender &Hohbein, Karlsruhe 
Water bath  Kötterman, Uetze, Germany 
2.2.  Chemicals 
 
1-phenyl-2Tricaine Sigma-Aldrich, Taufkirchen, Germany 
4',6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich, Taufkirchen, Germany 
Acetic acid  Merck, Darmstadt, Germany 
Agarose Peqlab, Erlangen, Germany 
Ammoniumacetate Merck, Darmstadt, Germany 
Ampicillin Roth, Karlsruhe, Germany 
Bacto Agar Roth, Karlsruhe, Germany 
Calcium acetate Roth, Karlsruhe, Germany 
Calciumchloride Sigma-Aldrich, Taufkirchen, Germany 
Chloroform Sigma-Aldrich, Taufkirchen, Germany 
Citric acid Roth, Karlsruhe, Germany 
Dimethylsulfoxide (DMSO) Fluka, Neu-Ulm, Germany 
Disodiumhydrogen phosphate Roth, Karlsruhe, Germany 
Dithiothreitol (DTT) Roth, Karlsruhe, Germany 
DNA-Ladder (1 kb) New England Biolabs, Frankfurt a.M, Germany 
DNA-Ladder (Mix)  Peqlab, Erlangen, Germany 
DNAseI Ambion Ltd, Warrington, UK 
dNTP Promega, Mannheim, Germany 
Ethanol (EtOH) Roth, Karlsruhe, Germany 
Ethidiumbromide Roth, Karlsruhe, Germany 
Ethylene diaminetetra acetic acid 
(EDTA) 
Roth, Karlsruhe, Germany 
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Formaldehyde  Merck, Darmstadt, Germany 
Gentamicin  Sigma,Taufkirchen, Germany 
Glycerol Roth, Karlsruhe, Germany 
GoTaq DNA polymerase  Promega, Mannheim, Germany 
Hydrochloric acid (HCl) Merck, Darmstadt, Germany 
Isoamyl alcohol  Roth, Karlsruhe, Germany 
Isopropanol Roth, Karlsruhe, Germany 
Kaliumchloride Sigma-Aldrich, Taufkirchen, Germany 
Kanamycin Sigma-Aldrich, Taufkirchen, Germany 
Leibovitz’s L-15 Gibco, Karlsruhe, Germany 
Low melting agarose Roth, Karlsruhe, Germany 
Luciferin Biosynth AG, Staad, Schweiz 
Magnesium chloride hexahydrate Roth, Karlsruhe, Germany 
Magnesium sulphate (MgSO4) Sigma-Aldrich, Taufkirchen, Germany 
Methanol (MeOH) Roth, Karlsruhe, Germany 
Methylene blue Interpret, Germany 
Nicotinamide adenine dinucleotide  New England Biolabs, Frankfurt a.M, Germany 
Nuclease free water  Ambion,Huntigdon,UK 
Oligonucleotides  Metabion, Planegg, Germany 
Paraformaldehyde Merck, Darmstadt, Germany 
Phosphate Buffered Saline (PBS) Life Technologies GmbH, Darmstadt, Germany 
PEG 8000  Promega, Mannheim, Germany 
Penicilin/Streptomycin Invitrogen, Karlsruhe, Germany  
Pfu-DNA polymerase Promega, Mannheim, Germany 
pGEMT-easy Promega, Mannheim, Germany 
Phenol Roth, Karlsruhe, Germany 
Phenol red Roth, Karlsruhe, Germany 
Phosphate buffered saline w/o CaCl2 and 
MgCl2 (PBS
-
/
-
) 
Invitrogen, Karlsruhe, Germany 
Plasmid safe nuclease  Biozym Scientific GmbH, HessischOldendorf, 
Germany 
Proteinase K Sigma-Aldrich, Taufkirchen, Germany 
Quick ligase New England Biolabs, Frankfurt a.M, Germany 
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Restriction endonucleases  Promega, Mannheim, Germany 
Restriction enzymes New England Biolabs, Frankfurt a.M, Germany 
Reverse transcriptase Promega, Mannheim, Germany 
Sodium acetate (NaAc) Roth, Karlsruhe, Germany 
Sodium chloride (NaCl) Roth, Karlsruhe, Germany 
Sodium citrate tribasic dihydrate Sigma-Aldrich, Taufkirchen, Germany 
Sodium Fluoride (NaF) Roth, Karlsruhe, Germany 
Sodium hydrogen carbonate (NaHCO3)  Roth, Karlsruhe, Germany 
Sodium hydroxide (NaOH) Roth, Karlsruhe, Germany 
Sodiumdodecylsulphate (SDS) Roth, Karlsruhe, Germany 
Sp6 RNA polymerase Life Technologies GmbH, Darmstadt, Germany 
T4 DNA Ligase New England Biolabs, Frankfurt a.M, Germany 
T4 DNA Polymerase New England Biolabs, Frankfurt a.M, Germany 
T5 Exonuclease Biozym Scientific GmbH, HessischOldendorf, 
Germany 
T7 RNA polymerase Life Technologies GmbH, Darmstadt, Germany 
T7 endonuclease I New England Biolabs, Frankfurt a.M, Germany 
Taq DNA Ligase New England Biolabs, Frankfurt a.M, Germany 
Taq-Polymerase Promega, Mannheim, Germany 
Tetracycline Roth, Karlsruhe, Germany 
Tris-base Roth, Karlsruhe, Germany 
Tris-HCl Roth, Karlsruhe, Germany 
Triton-X-100 Roth, Karlsruhe, Germany 
Trypsin 0.25% (w/v)-EDTA Gibco/Invitrogen, Karlsruhe, Germany 
TSAP Promega, Mannheim, Germany 
Tween 20 Roth, Karlsruhe, Germany 
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2.3.  Kits 
      MEGAshortscript™ T7 Kit                        Life Technologies GmbH, Darmstadt, Germany 
mMESSAGEmMACHINE  
Transcription Kits 
 Ambion, Darmstadt, Germany 
Nucleospin DNA purification kit   Macherey-Nagel, Düren, Germany 
PCR purification kit   Macherey-Nagel, Düren, Germany 
peqGold Gel extraction kit  Peqlab, Erlangen, Germany 
QIAGEN Plasmid Midi purification 
kit 
 Qiagen, Hilden, Germany 
QIAGEN Plasmid Maxi Kit   Qiagen, Hilden, Germany 
QIAquick Gel Extraction Kit  Qiagen, Hilden, Germany 
QIAquick PCR Purification Kit   Qiagen, Hilden, Germany 
  
2.4.  Software 
 
Ensembl Genome Browser 
Genome databases for vertebrates and other eukaryotic 
species 
http://www.ensembl.org/index.html 
UCSC Genome Browser 
Reference sequence and working draft assemblies for a 
large collection of genomes  
http://genome.ucsc.edu/ 
Primer3web version 4.0.0 
Online tool to pick primers from DNA sequence 
http://bioinfo.ut.ee/primer3/ 
PCR Primer Stats 
Online tool to evaluate potential PCR primers 
http://www.bioinformatics.org/sms2/p
cr_primer_stats.html 
OligoCalc 
Online oligonucleotide properties calculator 
http://www.basic.northwestern.edu/bi
otools/oligocalc.html 
ApE- A plasmid Editor v2.0.47 
Sequence editor using a modified GenBank format 
Davis M Wayne of University of Utah 
http://biologylabs.utah.edu/jorgensen/
wayned/ape/ 
The Basic Local Alignment Search Tool (BLAST)  http://blast.ncbi.nlm.nih.gov/ 
ClustalW2  
DNA or protein multiple sequence alignment program 
http://www.ebi.ac.uk/Tools/msa/clusta
lw2/ 
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Tal Effector Nucleotide Targter 2.0 
Online tool to design custom TAL effectors  
https://tale-nt.cac.cornell.edu/ 
Mojo Hand 
Online tool for genome editing applications 
http://talendesign.org/ 
ZiFiT Targeter version 4.2 
Online tool for genome editing applications 
http://zifit.partners.org/ZiFiT/Disclai
mer.aspx 
CHOPCHOP 
Online tool for genome editing applications 
https://chopchop.rc.fas.harvard.edu/in
dex.php 
GT-Scan Identifying Unique Genomic Targets 
Online tool for predicting optimal target sites  
http://gt-scan.braembl.org.au/gt-scan/ 
Pfam database 
A collection of protein families 
http://pfam.xfam.org/ 
 
2.5.  Oligonucleotides  
 
All oligonucleotides have been designed using the software “primer3” version 0.4.0 (Rozen & 
Skaletsky 2000), evaluated using PCR Primer Stat and purchased from Metabion GmbH, 
Planegg/Steinkirchen, Germany. 
 
Primers for PCR amplification 
gene Primer Fw Primer Rev 
ntl AATGGGCCACTTTGTACGTC CACCAATGAAATGATTGTCACC 
  CTGGATGAAAGCACCCGTAT 
id1 GCACCTCGCTTCAGCTATTC GATTCTCCAGCATGTCATCG 
Id3 CTTCCATCGTTCAGTGAGCA AAACACGCCTGACATTTTCC 
Id2a AACCAGCGAGTGAACAAACC ACATCCAGAACACCCCTGAC 
Id4 TGCGTTCACACTCAGAGAGG CAGAGCAGGTAAGCAGGACC 
sox1a ACTGGCTACAGGAGCGAAAA TACAGACCGAGGCGCAAAAC 
sox1b ACCGATCTCCTGTTCCAGTG GGTTAGAGAGTCCGGTGGGT 
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2.6.  TALEN target sites and binding sequences  
 
gene 
Target (Spacer) + 
Restriction site 
Binding site left Binding site right 
Enzy
me 
ntl TATGTCTGCCTCAAG T TTATTTGATCGGAAA TCCCGACCAGCGCCTGG MnlI 
id1 CAAGATCCCGCTGCT T TGGCCATCTCCAAATG GGACGAGCAGATGACC AlwI 
Id3 CCTCGCGATCAGCCG T GTATCTCGGAGCAGAG CTGCAAGAGTCCTTCCG NruI 
sox1a GATGGAAACGGACCT T GAATGTATAGCATGAT TCATTCCCCGGGACCCC BccI 
sox1b GATGGAGACGGACTT T GAATGTATAGCATGAT GCACTCTCCAGGAGCCC Esp3I 
 
2.7.  CRISPR target site and gRNA oligonucleotides 
 
gene Target + PAM Oligo1 Oligo2 NB 
ntl GGATCATCTCCTTAGCGCCGTGG TAGGATCATCTCCTTAGCGCCG AAACCGGCGCTAAGGAGATGAT fw 
ntl‘ GGTGACACTGGCTCTGAGCAGCC TAGGTGACACTGGCTCTGAGCA AAACTGCTCAGAGCCAGTGTCA rev 
id3 GGACTGATCGCCTTCATTCTCCC TAGGACTGATCGCCTTCATTCT AAACAGAATGAAGGCGATCAGT rev 
id3‘ GGACTTGTTCTGCGGGATGCACC TAGGACTTGTTCTGCGGGATGC AAACGCATCCCGCAGAACAAGT rev 
id2a GGCTGAGAGGATCGTCCACGCCC TAGGCTGAGAGGATCGTCCACG AAACCGTGGACGATCCTCTCAG rev 
id4 GGAAGCTTATGAGGGCGAACGCC TAGGAAGCTTATGAGGGCGAAC AAACGTTCGCCCTCATAAGCTT rev 
sox1a GGAAACGGACCTTCATTCCCCGG TAGGAAACGGACCTTCATTCCC AAACGGGAATGAAGGTCCGTTT fw 
sox1a‘ GGGGCAAACGGGTCCAAATTCGG TAGGGGCAAACGGGTCCAAATT AAACAATTTGGACCCGTTTGCC fw 
sox1b GGTCACACGGGACCCAACAGCGG TAGGTCACACGGGACCCAACAG AAACCTGTTGGGTCCCGTGTGA fw 
sox1b‘ GGAGTGGAAACTCATGTCCGAGG TAGGAGTGGAAACTCATGTCCG AAACCGGACATGAGTTTCCACT fw 
2.8.  Fish lines 
 
ll zebrafish embryos used in this study were of the wildtype Tübingen AB line. 
2.9.  Bacterial strain 
 
E.coli, Nova Blue®              Chemical competent cells (Invitrogen)  
                                             Genotype:K-12 strain 
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2.10.  Methods 
 
Preparation of Luria Bertani (LB)-medium: For 1L: 10 g tryptone, 5 g yeast extract, and 
10 g NaCl were dissolved in 950 mL deionized water. The pH of the medium was adjusted to 
7.0 using 1N NaOH and brought to a volume of 1 L. The solution was autoclaved on liquid 
cycle for 20 min at 15 psi and then stored at +4°C. If necessary, antibiotics were added before 
use (50 µg/ml ampiciline, kanamycine, spectinomycine; 10 µg/ml tetracycline). If tetracycline 
was used solution was stored in the dark. 
LB agar-plates: LB medium was prepared as mentioned above, but 15 g/L agar was added 
before autoclaving. After autoclaving it has been cooled to approximately 55°C. Antibiotics 
(if needed) were added and the solution was poured into Petri dishes. After hardening, plates 
were inverted and stored at +4°C (in case of tetracycline the storage is in the dark).  
Preparation of glycerol stock: To prepare a glycerol stock for the TAL Effector library of 
plasmids (see supplementary information, S.1), 5ml LB media was inoculated with a single 
colony and grown to mid log phase (carefully not allowing saturation). Then, 800 µl of the E-
coli culture was transferred in ao-ring tube and filled with 200µl autoclaved glycerol (80%). 
Tubes were carefully mixed by vortexing and stored at -80°C.   
Plasmid DNA extraction: Liquid cultures were prepared by inoculating 3 ml or 100 ml 
aliquots of LB medium (containing the appropriate antibiotic), for miniprep or maxiprep 
respectively, using single bacterial colonies. Plasmid DNA was extracted from saturated 
overnight cultures (at 37°C) using a column-based extraction system according to the 
manufacturer’s instructions, for small yield (NucleoSpin® Plasmid, Macherey-Nagel) or high 
yield (Qiagen Plasmid Maxi kit) of DNA preparation. The pellets were dissolved in 50 µl to 
100 µl Millipore water. Yields of DNA were calculated based on optical density 
measurements of dilutions made from the stocks. The optical density was measured at both 
260 nm and 280 nm and used to assess DNA purity as well as concentration (NanoDrop, 
Peqlab). 
DNA Digestion: DNA is digested as follows:  10 µg total DNA 
10 µl 10x buffer 
2 µl restriction enzyme (10 U/µl) 
Adjusting water to 100 µl 
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The reaction is incubated at 37°C (or depending on the enzyme requirements). 1 µl of the 
digestion is loaded on a 1.5% agarose gel for verification (adding 4 µl water and 1 µl blue 
loading dye). 
Phenol/chloroform purification: For phenol/chloroform purification of plasmid DNA, 100 
µl of plasmid containing solution was mixed with 100 µl of phenol/chloroform (1:1 v/v) and 
mixed by vortexing for 10 sec before centrifugation at 14000 g for 2 min at room temperature 
(RT). Following the centrifugation, the supernatant was carefully removed (avoiding 
interphase) and transferred into a clean 1.5 ml Eppendorf tube. 100 µl of chloroform were 
added to the supernatant and again vortexed and centrifuged under the same conditions. The 
new supernatant was transferred into a fresh Eppendorf tube and 100 µl isopropanol (100%) 
was added and the mix was stored for at least 30 min at -80°C before centrifugation at 13000 
g for 25 min at 4°C. The resulting DNA pellet was washed with 200 µl of ethanol (75%) and 
re-centrifuged for 10 min at 4°C. Supernatant was carefully removed and the DNA pellet was 
air dried at RT for about 15 min before resolving in 16 µl of RNase free water by pipetting up 
and down several times. The DNA was then stored at -20°C.    
Agarose Gel Electrophoresis: For size and quality check, DNA fragments are separated by  
electrophoresis. Depending on the expected size of the DNA fragments, agarose gels with a 
concentration varying from 1.0% to 2.0% were prepared. For the visualization of the DNA on 
a UV-transilluminator, Ethidium Bromide at final concentration of 0,5 μg/ml is added. Before 
loading, the samples are supplemented with loading dye (NEB) and the electrophoresis is 
carried out in 1xTAE electrophoresis buffer with 3 -5 V/cm intensity of electric field. An 
appropriate DNA marker (DNA ladder, NEB) was loaded in parallel for determining the size 
and the approximate quantity of the DNA samples. 
Isolation of DNA from agarose gel: For cloning purposes or microinjections, DNA 
fragments resulting from a restriction digest or PCR were separated by agarose gel 
electrophoresis. The band containing the desired DNA fragment was cut out from the gel and 
purified with the peqGOLD gel extraction kit was used following tightly the manufacturer’s 
protocol.  
Polymerase Chain reaction (PCR): The amplification of DNA fragments from genomic 
DNA or plasmids is performed by PCR. Two enzyme systems were used depending on the 
purpose. Ordinary Taq polymerase was used when proof reading activity was not needed (for 
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example colony PCR tests). Proof-reading polymerases were utilized for the amplification of 
DNA fragments for cloning purposes. The PCR was performed according to the user manuals 
provided with the enzymes, with adjustment of the annealing temperature and elongation time 
according to the used primers and the size of the amplified fragments. All PCRs were 
performed on a thermocycler (Biozym Scientific). 
Colony PCR: Colony PCR was used to quickly screen and identify the correct size of 
plasmid fragments present in E. coli colonies.  
A reaction was set up as follows: 
PCR mix:  
5 µl 10x buffer (500 mM KCL, 100 mM Tris-HCL(pH9.0), 1,0% Triton X 100) 
1 µl dNTPs (10 mM each dATP, dTTP, dGTP, dCTP) 
1 µl 20 µM forward primer 
1 µM 20 µM reverse primer 
0.2-1µl Taq polymerase (GO, Pfu (for proofreading)) 
Adjusted water to 50 µl total reaction volume 
 
All reactions were set up on ice and the enzyme was added last. To each pre-chilled tube 
containing the PCR mix, 2 µl of bacterial colony was added. The tubes were placed into a 
thermocycler for PCR reaction. PCR conditions varied within the experiments regarding the 
requirements for the desired fragments.  
Ligation: Ligation was performed within 5 min at room temperature using the Quick ligation 
kit (NEB) according to the manufactures protocol.  
Bacterial transformation: For transformation 1 µl DNA was added to 50 µl of competent 
bacterial cells. After incubation on ice for 20 min. a heat shock was performed for 45 sec. at 
42°C. The transformations were kept on ice for another 10 min. before adding 500 µl of LB-
medium. Then cells were shaken for 15-30 min at 37°C before plated onto respective LB and 
antibiotics containing agar plates for colony growth over night at 37°C.  
Zebrafish care: The zebrafish work was conducted along the guidelines of the European 
Zebrafish Research Center (EZRC-KIT). Wildtype zebrafish danio rerio (AB line, University 
of Oregon; Eugene, USA) were raised, bred and crossed according to standard methods,  
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maintained on a 14 h/10 h light-dark cycle at 28.5°C in recirculation systems (Schwarz Ltd 
Germany, Müller and Pfleger Ltd Germany) and fed commercial food and in-house hatched 
brine shrimp as described (Westerfield, 2007). All zebrafish husbandry and experimental 
procedures were performed in accordance with the German animal protection standards and 
were approved by the Government of Baden-Württemberg, Regierungspräsidium Karlsruhe, 
Germany. Fertilized eggs were collected within 2 h of laying and transferred into petri dishes 
(10 cm diameter) containing E3 medium and the fungicide methylene blue (1 mg/ml). E3 
medium was changed regularly.  
TALEN target site design: The TAL Effector Targeter (TALEN-T) software (https://tale-
nt.cac.cornell.edu/) (Doyle et al. 2012) was initially used to design TALEN candidates, 
according to three criteria: a Thymine start, the TALEN binding site length ranged from 15-25 
bases, the spacer region between 15 and 30 base pairs (bp), and a possible restriction site 
within the spacer to simplify downstream analysis. However, the use of the GoldyTALEN 
backbone (available from Addgene, 38142) restricted the length of the spacer region to 15-16 
bp. Another, simple, open access software, Mojo Hand (http://talendesign.org/), was used 
(Neff et al. 2013).  
TALEN synthesis: The assembly of the TALEN binding domain, with the repeats containing 
the proper RVDs was performed using the Golden Gate approach (Cermak et al. 2011). Each 
TALE binding site (left or right arm) is designed to target 15 to 17 bp DNA of interest. The 
first assembly is performed with cut-ligation method using the endonuclease BsaI (New 
England Biolabs). The primers pCR8_F1 and pCR8_R1 (supplementary information, S.2) are 
used to sequence the intermediate products. The positive arrays are purified (NucleoSpin® 
Plasmid, Macherey-Nagel) and introduced with cut-ligation procedure, using the 
endonuclease Esp3I (Life Technologies), into the GoldyTALEN expression plasmid 
containing the wild-type FokI catalytic domain (available from Addgene, 38142). All 
obtained TALEN expression vectors were verified by sequencing using the primers: 
SeqTALEN_5-1 and TAL_F2 (supplementary information, S.2). DNA purification for high 
yield of the final DNA constructs is performed (Qiagen Plasmid Maxi kit) and the 
concentration is assessed (Nanodrop). 
TALEN mRNA synthesis and microinjection: In vitro transcription was performed after 
linearization of the plasmid with SacI endonuclease (New England Biolabs) at 37°C overnight 
digestion. 5’-capped and tailed mRNAs were generated (T3 mMessage Machine kit, Ambion; 
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Poly(A) tailing kit, Life Technologies) and purified by phenol/chloroform extraction. The 
mRNA was injected into one-cell stage zebrafish embryos at a concentration of 100 ng/μl 
(approximately 200 pg per target). 
DNA isolation from embryos: Genomic DNA was extracted at 72 hours post-fertilization 
(hpf) from 30-50 individual larvae, by incubating in 20 mg/ml Proteinase K mixed with TE 
buffer (10 mM of Tris-HCl pH 8.0, 1 mM of EDTA), at 55°C for 240 min, followed by 
heating at 94°C for 10 min before cooling down to 4°C. 
Analysis of somatic mutations with TALENs: Targeted genomic regions were amplified 
from the isolated genomic DNA by PCR, using primers which anneal between 200 and 800 
bp upstream and downstream from the expected cut site. The purified PCR products were 
suggested to restriction digestion with enzymes recognizing the regions to be cleaved (New 
England Biolabs or Life Technologies). The fragments are assessed by gel electrophoresis and 
the positive ones are purified and cloned into the pGEM-T easy vector (Promega). After 
transformation of the ligated vectors, single colonies were re-inoculated for plasmid DNA 
isolation (NucleoSpin® Plasmid, Macherey-Nagel) and sequencing (using M13 primers). All 
primers used for DNA amplification are shown in Table 3. 
CRISPR target site design and construction: Potential targets for the sgRNA-Cas system 
were identified according to the ZiFiT Targeter website (http://zifit.partners.org/), and 
following the criteria: 5’-GG-(N)18-NGG-3’. The appropriately designed oligonucleotides 
(Table 2) were annealed and introduced into the expression plasmid pDR274 (available from 
Addgene, 42250) digested with BsaI restriction enzyme (New England Biolabs). All obtained 
sgRNA expression vectors were verified by sequencing (using M13 primer). After DraI (New 
England Biolabs) digestion of the expression vector, the sgRNAs were transcribed in vitro 
(T7 mMessage Machine kit, Ambion). The vector encoding the Cas9 nuclease (available from 
Addgene, 46757) was linearized with XbaI restriction enzyme (New England Biolabs) and 
transcribed in vitro (T3 mMessage Machine ultra kit, Ambion). Both the sgRNA and the Cas9 
encoding mRNAs were then purified by phenol/chlorophorm extraction and concentrations 
were assessed (Nanodrop). The mRNAs were co-injected into one-cell stage zebrafish 
embryos. The mixed solution contained 25 pg of sgRNA and 150 pg of Cas9 mRNA per 
target, approximately. 
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T7 endonuclease assay: After 3 days post injection, injected and un-injected embryos are 
collected and the genomic DNA is extracted from single embryos as described before. 
Targeted genomic regions were amplified using primers designed to anneal upstream and 
downstream of the expected cut site (Table 3, Annex). PCR products were purified according 
to the manufacturer’s instructions (Nucleospin® Gel and PCR clean-up, Macherey-Nagel). T7 
Endonuclease I (New England Biolabs) assay was performed following published protocols 
(Jao et al., 2013). 2 μl of 10xNEB 2 buffer (New England Biolabs) was added to 200 ng total 
PCR product. The DNA sample was re-annealed for formation of heteroduplex, as follows: 
95°C for 5 min, 95 to 85°C decreasing by -2°C/s, then ramping until reaching 25°C at -
0.1°C/s. 10U of T7 Endonuclease I was added to the DNA and incubated at 37°C for 15 min. 
The digested products were loaded on an agarose gel for electrophoresis. 
Genotyping by fin biopsy: Fish are anesthetized by immersion in 0.004% MS-222 (Tricaine, 
Sigma) until gill movement is slowed. The anesthetized fish is placed on a clean surface 
where the fin is clipped with a sterilized scalpel. The amputated fin is transferred into a sterile 
1,5μl eppendorf tube containing 100 μl of self made tail buffer (1M Tris-HCl pH 8.5, 5M 
NaCl, 0,5M EDTA, 10% SDS, 10mg/ml Proteinase K). After overnight incubation at 62°C, 
the genomic DNA is extracted with Isopropanol, washed with 70% Ethanol and re suspended 
in nuclease-free water. The samples are stored at 4°C. 
pGEM T easy: The PCR products from targeted sequences are cloned into pGEM T easy 
vector using the T4 DNA ligase. After incubation of 1h at room temperature, bacterial 
transformation is performed and followed by selection of transformants on LB/Ampicillin 
plates. 
DNA Sequencing: Purified pGEM T positive clones and purified PCR products are 
sequenced according to the company requirements by M13 primer and primers used for 
amplification, respectively. All sequencing in this study is done by Microsynth AG (Sanger 
Sequencing Division). Single insertions, deletions or substitutions were considered as PCR or 
sequencing artefacts. All primers used for sequencing are shown in Table 2 (Annex). DNA 
sequence alignments were performed using Fish Factor Database global alignment 
(http://141.52.98.21/ffdb/gloal.php) and ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/).  
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Chapter III: RESULTS 
In the whole-genome screen performed in our laboratory few years ago, 3302 potential TR 
genes were identified in the zebrafish embryo. The cDNAs of 2149 TRs were cloned and the 
expression pattern of 1711 TR genes was obtained by in situ hybridization at 24 hpf (Armant 
et al. 2013). Among the identified TRs, two interesting regulators: Sox1a and Sox1b were 
expressed in the brain and in distinct cells of the spinal cord. Our group was interested in the 
cells expressing sox1a and sox1b in the V2 domain of the spinal cord, in order to investigate 
regulators of the specification of V2 interneurons (Yang et al., unpublished data).  
Another systematic screen was performed to identify TRs implicated in adult neurogenesis 
and brain regeneration of the zebrafish. The expression analyses were fulfilled by in situ 
hybridization in the intact and injured adult zebrafish telencephalon. From this study, an 
expression map of more than 1200 TRs was established in the adult zebrafish telencephalon 
and 279 TR genes were identified to be misregulated after brain injury (Diotel et al. 2015; 
Viales et al. 2015). Among them, id1 drew attention as it was shown to be expressed in the 
VZ of the adult telencephalon and to be upregulated after injury.  
In spite of previously performed studies on these target genes using morpholino knockdown 
and overexpression (cf. Introduction), many grey areas persist in the comprehension of the 
molecular mechanisms in which they are implicated. For this reason, we had established in 
our laboratory genome editing technology for genetic mutagenesis and I created heritable 
mutations in several target genes. Hence, zebrafish knockout lines can be obtained in order to 
be used as a null background for further molecular investigations.  
The overall aim of the current PhD project has been to use loss-of-function strategies to study 
the molecular mechanisms involved in neurogenesis and adult brain regeneration, focusing on 
our preferred genes: id and sox1. To that purpose, I first had to establish in the laboratory 
newly developed gene-targeting methods; Transcription Activator-Like Effector Nucleases 
(TALENs) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR).  
3.1.  Launch of TAL effector technology for use in zebrafish 
At the beginning of this project, the TAL effector technology just came out on the field of 
genome editing and little was known about the different methods to create TALENs and their 
efficiency in zebrafish (Sander et al. 2011; Huang et al. 2011). As the Golden Gate assembly 
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was well documented and simple to use in an average laboratory, it was a suitable method for 
the start of our study (Cermak et al. 2011). 
3.1.1.  Golden Gate Assembly of TALENs 
As previously mentioned (cf. Introduction), the Golden Gate cloning is based on type IIS 
restriction enzymes, which digest DNA outside of their recognition site and leave 4 
nucleotides overhangs. These sequences can be designed in a way to generate unique 
complementary ends between several fragments that can be ligated in an ordered fashion 
(Figure 15) (Engler et al. 2009).           
The Golden Gate assembly of TALENs consists of two steps:  
 A first reaction to assemble the modules into intermediate arrays of 1-10 repeats; 
 A second reaction to obtain the final construct, by introducing the intermediate arrays 
with the last half-repeat into an appropriate backbone. 
 
Figure 15: Type IIS endonuclease mode of function for Golden Gate cloning. Type II restriction 
enzymes recognize a short sequence of 6 bp and cleave close to their recognition site leaving 5’-
overhangs of 4 bases. The example of Esp3I (or BsmBI) is shown in (A). (B) Two DNA fragments can 
be designed with chosen ends flanked by a type IIs restriction site. The digestion of the fragments 
generates ends with complementary 4 nt overhangs while removing the recognition site. These ends 
can be then ligated in an ordered fashion.  
(B) 
(A) 
 
(A) 
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A library of 72 plasmids was available from Cermak et al. (Golden Gate kit, supplementary 
information S.1), containing:  
- Repeat modules for 10 successive positions (designed overhangs) with the various 
RVDs: pHD (binding to C), pNG (binding to T), pNI (binding to A), pNN (binding to 
G or A) and pNK (binding to A, C, T or G). 
- Last half-repeat plasmids for the five different RVDs: pLR-RVD.  
- Array plasmids for the intermediary assembly: pFUS_A (which can contain 10 
modules), pFUS_B1 – pFUS_B10 (which can contain 1 to 10 modules). 
- Backbone plasmids: pTAL1 – 4 (yeast expression vectors).   
After obtaining a bacterial stock from each item (from a collaborative laboratory), DNA 
purification by maxi-preparation was performed for each and every plasmid and a glycerol 
stock was produced.  
The designed TALEN is constructed as follows according to the Voytas protocol (Cermak et 
al. 2015): 
1) Ist Assembly, in which the first 10 RVD modules are cut with the type IIS enzyme 
BsaI and ligated in the same reaction to each other and into the pFUS_A intermediate 
array. The remaining number of modules according to the final length of the TALE 
(from 1 to 9) is assembled with the same procedure into the appropriate intermediate 
array (pFUS_B1 – pFUS_B10). The reactions are incubated in a thermocycler for the 
fragments to be digested and ligated (Figure 16, (A/B)); 
2) Treatment with Plasmid Safe DNase to eliminate unligated linear fragments 
(incomplete products or linearized plasmids); 
3) Transformation into Escherichia coli (E.coli), then selection of colonies for overnight 
bacterial culture in order to purify the DNA (the intermediate arrays contain 
Spectinomycine resistance). The isolated plasmids are sequenced to identify the 
correct arrays; 
4) IInd Assembly, the 10 containing intermediate arrays are joined with the following 1 to 
10 second arrays and with the appropriate last half-repeat into the desired backbone, 
by cut-ligation reaction. The digestion in this mixture is performed by the type IIS 
enzyme Esp3I (Figure 16, (C)); 
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5) After transformation into E.coli and overnight culture (the backbones contain 
Ampicillin resistance), the final construct containing the TAL array fused to FokI is 
purified and characterized by DNA sequencing (Figure 16, (D)).  
 
Figure 16: Representation of the outlines of the Golden Gate assembly of TALENs. (A) 
Representation of the four modules coding for the main RVDs with different colors (NG, NI, HD, 
NN). (B) The Ist Assembly consists of using the endonuclease BsaI which cuts outside its recognition 
site and leaves 4 bp overhangs. The cleaved modules are then ligated to each other in an ordered 
manner, into intermediary arrays, and the constructs A (of 10 RVD modules) and B (of 7 RVD 
modules) are obtained. (C) In the II nd Assembly, the constructs A and B are ligated using the same 
principle with the endonuclease Esp3I, with the addition of the last half-repeat, into the final 
expression backbone containing a T3 promoter driving the TAL cassette and the catalytic domain of 
the endonuclease FokI. (D) The final TALEN construct is represented with the complete DNA-binding 
domain, fused to the FokI protein and driven by the T3 promoter (simplified pGoldyTALEN). The 
used RVDs: NG = T; NI = A; HD = C; NN = G or A. 
 
3.1.2.  First steps for the assembly of customized TALENs 
As this study began, the efficiency of the TALEN technology was not as well documented as 
nowadays. In the first attempt to implement this kind of strategies, a trustworthy control to 
assess the efficiency of our designed TALENs was therefore elaborated. The no-tail (ntl) gene 
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was interesting for us to be used as a positive control because of its clear phenotype. The 
zebrafish ntl gene is the homologue of the mouse T gene, or Brachyury, early expressed and 
required for development of the mesoderm and the establishment of the body axis in 
vertebrates (Schulte-Merker et al. 1994). The mutant phenotype is similar to the one described 
in mouse, with the lack of a differentiated notochord and all the posterior structures, but the 
anterior structures seem to develop normally. The zebrafish ntl gene was also shown to 
encode a transcription factor (Kispert & Herrmann, 1993). 
First of all, TALENs against the ntl gene were designed with the TALEN Targeter online tool 
(cf. Introduction) and assembled using the Golden Gate method. Unfortunately, the first 
attempts to construct the TAL intermediary arrays were unsuccessful. We argued that the 
issue might come from the modules themselves. Indeed, control assemblies with random TAL 
repeats were performed and showed anomalies in some of the plasmids defining the different 
positions of the polymorphic residues. Thus, indicating a confusion of constructs in the given 
library. In order for us to identify the mixed constructs, we started to assemble into the 
pFUS_A intermediate array, each of the 10 RVDs recognizing the same bases. For instance, 
the modules NG 1 to 10 were assembled and when one of the RVDs was not at its right place, 
the assembly wouldn’t work. By that, the type of the wrong RVD was identified and then we 
tested individually each of them by random construction using already assured modules and 
their integrity was confirmed by sequencing. The whole library was therefore tested and then 
the right order of the RVDs was restored.  
As mentioned above, the I
st
 assembly was the first to be achieved: The first 10 modules were 
mixed in a solution containing the pFus_A intermediate array, the BsaI type IIs endonuclease 
and the T4 ligase. The last remaining modules, here 6, were mixed in a similar solution except 
for the intermediate array that was pFus_B6. After the thermocycling procedure and the 
bacterial culture, the resulting fragment was checked by colony PCR using a supplied primer 
set (pCR8_F1 and pCR8_R1, supplementary information S.2) and then visualized on an 
electrophoresis gel. The results are shown in figure 17 for three different clones: The first 
array “pFus_A” can be observed with a prominent band at around 1200 bp of length, while 
the second array “pFus_B6” is represented with a smaller band of about 800 bp. Smearing and 
a “ladder” of bands is also observed every 100 bp resulting from the presence of repeats and 
indicating a positive clone (Figure 17A-left panel).  
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Figure 17: Construction and injection of TALEs against the no-tail gene. (A) Gel electrophoresis 
representing the 1
st
 and the 2
nd
 assemblies of TALENs against ntl with the DNA ladder used for all 
experiments. The 1
st
 assembly comprises intermediate arrays containing 10 repeats (pFus_A ~ 1.2 Kb 
in 3 clones) and the second array containing 6 repeats (pFus_B ~ 0.8 Kb in 3 clones) (left panel). The 
2
nd
 assembly represents the ligation of pFus_A and pFus_B with the last half-repeat in the vector 
backbone giving a band of ~ 1.8 Kb (right panel). (B) Gel electrophoresis showing the in vitro 
transcribed mRNA with the corresponding size of both left and right TALENs (T1 and T2 ~ 3.5 Kb), 
with the mRNA of CFP as a control (1 Kb). An RNA ladder is used to assess the size of the RNA. (C) 
Representation of the Sp6:TAL-GFP used as a vector backbone containing the TAL cassette fused to 
GFP with an NLS and a polyadenylation signal (pA) and under the Sp6 promoter. The vector also 
comprises Tol2 arms and resistance to ampicillin (Amp
R
). (D) Visualisation of the expression of the 
destination vector containing GFP fused to TALE against ntl at 6 hpf. 
For the II
nd
 assembly, the first used backbone pTAL1 from the library, was derived from a 
precursor to TALEN yeast expression vector (Cermak et al. 2011).  The TAL cassette consists 
of a fragment of a natural occurring TAL effector gene used as a context for custom repeat 
arrays. During the assembly step, the same disorder issue occurred and all the last half-repeats 
had to be tested individually and indeed some were altered. They were controlled by 
sequencing and their integrity was ensured. Thanks to that, de novo designed TAL effectors 
were successfully assembled and cloned into the final backbone. Similarly to the I
st
 assembly, 
the final assembled constructs were produced by mixing the two intermediate repeats (A and 
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B6) with the backbone and the corresponding last half-repeat in a solution containing the 
second type IIs endnuclease Esp3I with the T4 ligase. The resulting clones were then tested 
by colony PCR using a supplied primer set (pTAL_F1 and pTAL_R2, supplementary 
information S.2) and visualized on an electrophoresis gel. The positive clones show a 
prominent band around 1800 bp with the smearing and the “ladder” effect (Figure 17A-right 
panel). 
The pTAL1 vector, like the other available backbones from the kit, was optimized for use in 
yeast, and thus do not have the requirements for expression in zebrafish. For this reason, an 
expression vector containing the Sp6 bacteriophage promoter with a polyadenylation (polyA) 
signal for transcription termination and a Kozak sequence to ensure the eukaryotic translation 
of a functional TALEN was designed and created. Tol2 arms were also added to facilitate 
genome integration that can be used in further investigations. The TAL cassette that will 
receive the designed binding site was derived from the available pTAL3 vector containing 
also the Fok1 protein and a nuclear-localization signal (NLS). The resulting vector was named 
Sp6:TAL-FokI. Another alternative vector was created by replacing the FokI protein with 
GFP; Sp6:TAL-GFP (Figure 17C) (M. Ferg, unpublished data).  
The injected embryos with both constructs (Sp6:TAL-GFP and Sp6:TAL-FokI) against ntl 
were observed under a stereo microscope. At 6 hours post-fertilization (hpf), GFP was 
detected mosaically spread in the embryos (Figure 17D). Alas, no phenotype was observed 
with the FokI version of the construct, also at later stages. However, the DNA had to be 
assessed in order to identify possible mutations. To achieve that, the genomic DNA of a pool 
of 10 injected embryos and the DNA of wild-type embryos was extracted, following the 
published protocol (Sander, Cade, et al. 2011). A fragment of about 200 bp upstream and 
downstream of the target site was then amplified by PCR and the amplicon was sub-cloned 
into the pGEM T easy vector system (Promega). A number of clones was subsequently 
sequenced without success in detecting mutations. 
When a truncated version of the TALEN was  shown to be more efficient in zebrafish  (Bedell 
et al. 2012), it immediately caught my interest and the vector was ordered from Addgene 
(plasmid #38142) (Carlson et al. 2012). This newly developed TALEN destination vector was 
obtained by truncating the pTAL scaffold by 152 amino acids at the N-terminus (a region that 
has only a function for transport into plant cells), with +63 amino acids at the C-terminal 
region (originally 278 residues) (Miller et al. 2011). This TALEN scaffold was then adapted 
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to the Golden Gate assembly method and introduced into a messenger RNA expression vector 
driven by the T3 promoter (based on pT3Ts vector), resulting into the pGoldyTALEN 
backbone (Figure 18A) (Carlson et al. 2012).  
Additionally, to optimize and facilitate downstream analyses of the TALEN effects, the 
spacer region would be designed in a sequence containing a centrally located restriction site. 
Actually, when the TALEN mutates the DNA in this region, the recognition site of the 
enzyme would be disrupted preventing the cleavage. This strategy can be easily used as a 
read-out for presence of mutations at the target site; only by subjecting the amplified region of 
interest to restriction digestion and the result can be observed on an electrophoresis gel (the 
presence of an uncut band determines the presence of mutations). The amplified fragment is 
then cloned into the pGEM T easy vector in order to determine the type of mutations 
occurring at the DNA level.  
3.1.3 Successful obtaining of a ntl phenotype using the TALEN technology 
After the development of the GoldyTALEN plasmid backbone, a new TALEN pair against 
the gene ntl was designed in the first exon of the gene, around the start codon ATG, according 
to new criteria using the Mojo Hand online tool. Indeed, as the C-terminal region which is 
fused to the FokI domain is truncated, the spacer needed to be shorter in order to grant the 
dimerization of FokI. The binding sites of the left and the right TALEN proteins had lengths 
of 14 and 16 bases, respectively, with a spacer region of 15 bp. The recognition site of the 
enzyme MnlI was present in the middle of the spacer sequence. The in vitro transcription 
using the T3 promoter and the addition of the polyA signal (as the vector did not contain one) 
were performed. Then the mRNAs of each TALEN (left and right) were verified by 
electrophoresis, and equal amounts of the two TALEN parts were co-injected into one-cell-
stage embryos of zebrafish. First of all, different concentrations were tested (60, 100, 300, 500 
and 800 ng/μl).  
After 24 hpf, injected embryos with ntl-TALENs showed a similar phenotype to the ntl one, 
characterized by the absence of the posterior structures and a differentiated notochord, 
compared to the wild type uninjected embryos (Figure 18B, left panels). After 72 hpf, an even 
more clear phenotype was observed with the lack of the posterior part (Figure 18B, middle 
and right panels). 
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The ntl phenotype was observed at all tested concentrations in this first experiment, compared 
to uninjected wt fish. Just by counting the number of fish showing different effects of the 
injections, some tendencies could be observed. For instance, the phenotype seems more 
specific at concentrations within a range from 60 to 300 ng/μl, while increasing the 
concentration results in severe deformations of the embryos bodies, including heart oedema 
and head malformation, most probably caused by higher toxicity with also an increase of 
death (Figure 19). 
 
 
Figure 18: The pGoldyTALEN backbone and its successful use in obtaining a ntl phenotype. (A) 
Representation of the pGoldyTALEN with truncations on the N- and C-terminal parts of the TAL cassette 
that is fused to the FokI catalytic domain and under the T3 promoter. It also contains an NLS and 
resistance to ampicillin (Amp
R
). (B) ntl phenotype observation after TALEN injection. The upper panel 
shows a wild-type zebrafish embryo at 24 hpf and at 72 hpf with a closer look at the trunk (from left to 
right). The bottom part shows the same stages for an embryo injected with both left and right ntl-
TALENs and the clear lack of the posterior part is observed, while the overall shape of the anterior part 
seems normal. 
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Figure 19: First tested concentrations of ntl-TALENs and their effect on zebrafish embryos. At 
48 hpf, the injected embryos were observed under stereomicroscope and counted according to the 
observed effect (here converted into percentages). The ntl phenotype was observed at all 
concentrations except in uninjected embryos used as a negative control (green). A high rate of the ntl 
phenotype was observed at 100 ng/μl. Unspecific effects depict embryos malformations that do not 
correspond to the known ntl phenotype (red). The number of dead and normal looking embryos was 
also counted (purple and blue, respectively).  
 
In order to analyze the DNA for loss of restriction enzyme recognition site that present at the 
expected cleaved region, the genomic DNA was extracted from about 30 single embryos at 3 
days post-fertilization (dpf): 2x from wt, 18x from 100 ng/μl injected embryos and 10x from 
300 ng/μl injected embryos as they showed the best rate of observable phenotype. The 
fragments of interest were then amplified by PCR, and digested with the appropriate enzyme 
MnlI. 20-30% of the tested embryos showed mutations at the restriction site on gel 
electrophoresis: the amplified fragment from a wild type embryo with a size of 426 bp (uncut) 
was submitted to digestion with MnlI and two bands of 270 bp and 155 bp resulted from it 
(cut) (Figure 20A, wt-embryo). The amplification and the digestion of the fragment from 
injected embryos with TALENs gave also the same bands, with the difference that an uncut 
band was still present in addition of the cut bands (Figure 20A, mut-embryo). Thus, 
suggesting indeed a disruption of the recognition site of the restriction enzyme MnlI in some 
cells of the zebrafish embryo. A statistical analysis for three different experiments placed the 
mutation rate to 35% of the tested embryos (Figure 20B). A positive fragment was 
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subsequently cloned into pGEM T easy vector and the clones were subjected to sequence 
analysis using the M13 standard primers. About 30% of the tested clones confirmed the 
presence of insertions or deletions of varying lengths (e.g. deletion of 4 bp in Mut1, insertion 
of 14 bp in Mut2) compared to the wild type sequence (WT) (Figure 20C).  
 
Figure 20: Identification of mutations induced by TALENs in the ntl gene. (A) Gel electrophoresis 
showing the targeted fragment of the gene ntl of 426 bp (n/d for undigested) submitted to the 
restriction enzyme MnlI (d for digested). The genomic DNA extracted from a wild type embryo was 
used as a negative control (Wt-embryo) and the digested fragment gave rise to 2 bands of about 270 bp 
and 155 bp (cut). The DNA fragment from an injected embyo (mut-embryo) showed the same 2 cut 
bands with the presence of a remaining uncut band. (B) Statistical representation of the number of 
mutated embryos injected with the ntl-TALEN from 3 different experiments. 35% of the embryos 
showed mutations at the target site. (C) Examples of mutations at the target site compared to a WT 
control sequence. Mut1 shows a deletion of 4 nt and Mut2 shows an insertion of 14 nt (red). (D) 
Embryos injected with pGoldyTALEN and sp6:gTALEN against the ntl gene were observed under 
stereomicroscope at 24 hpf. The ntl phenotype was observed for both constructs with comparable rates 
of about 25% (green) while no ntl phenotype was observed in uninjected embryos. The number of 
normal looking and dead embryos are also represented (blue and purple, respectively).  
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To keep a high mutation probability with low toxicity, the tested concentration of 100 ng/μl 
was chosen to be used in the following experiments of this study as it showed best results in 
mutations and a clear ntl phenotype with low unspecific and toxic effects. Following 
experiments using the ntl-TALENs were performed in order to test and compare the 
efficiency of a the created vector Sp6:TAL-FokI after replacing the TAL cassette with the the 
truncated one used for the pGoldyTALEN (Ferg, unpublished data). Injected embryos with 
pGoldyTALENs and Sp6:gTAL-FokI against the ntl gene were counted from three 
independent experiments and as shown in figure 20D, the percentage of embryos with an 
observable ntl phenotype are comparable for both constructs. However, a slightly higher death 
effect was observed with the Sp6:gTAL-FokI. These experiments also allowed us to note the 
efficiency rate of the ntl-TALENs which lies between 25% and 30%.  
The specific phenotype and the presence of mutations at the target site of the ntl gene suggest 
that de novo customized TALENs according to the aforementioned procedure are quite 
efficient to induce gene modifications in zebrafish. 
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3.2.  Launch of the CRISPR/Cas method for use in zebrafish 
During the realization of the current study, another new genome targeting method emerged 
and was developed for the use on the zebrafish model: the clustered regularly interspaced 
short palindromic repeats, or CRISPR (Hwang et al. 2013). Due to the simplicity and the fast 
development of this technique, it was in our interest to establish it and to use it in an ordinary 
basis. Indeed, the targeting using the guide RNAs (gRNAs) is as easy as to design an 
oligonucleotide and the costs are much lower compared to the TALEN construction and even 
to the morpholino oligonucleotides. Furthermore, the method showed good results for 
multiplex gene targeting in zebrafish (Jao et al. 2013a) allowing to study several genes 
simultaneously in this model organism (e.g. id genes, sox1 genes).  
3.2.1.  First steps in using the CRISPR technology 
Like for the TALENs at the beginning of this study, we started using the CRISPR technology 
right after its coming out on the market. For this, the use of a proper control was also 
essential. Taken the fact that the no-tail gene was profitable to test the TALEN method, the 
same target was used as a proof of principle for the first experiments using the CRISPR/Cas 
system.  
 
First of all, a gRNA was designed using the ZiFiT Targeter software (cf. Introduction) to 
target a 20 nucleotides sequence downstream of the ATG start codon, in the first exon of the 
ntl gene (Figure 21A). The gRNA was constructed by annealing two complementary 
oligonucleotides of 24 nt, with selected overhangs in both ends. The expression vector 
pDR274 carrying a T7 promoter from Joung’s lab (Hwang et al. 2013), tested in zebrafish and 
available from Addgene (plasmid #42250), was used to clone the double stranded gRNA. 
BsaI restriction enzyme from the type IIs endonucleases family was used to cut and to create 
the corresponding overhangs for the fragment to be introduced into the vector (Figure 21B). 
 
In the same publication from Hwang et al., the Cas9 nuclease used to create mutations in the 
zebrafish genome was derived from Streptococcus pyogenes, with the addition of a T7 
promoter 5’ site and a nuclear-localization signal (NLS) at the C-terminal region. Following 
the published protocol, both gRNA and Cas9 mRNAs were injected into one-cell stage 
zebrafish embryos, with concentrations of 12.5 ng/µl and 300 ng/µl, respectively. After 24 
hpf, the injected embryos were observed under stereo microscope, but no specific ntl 
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phenotype was detected. On the other hand, many other unspecific malformations, including 
heart oedema, were observed in a number of embryos. This would be explained by the large 
concentration of the injected Cas9 mRNA that would lead to higher toxicity. However, 
reduction of this concentration in following injections did not give more promising results. 
We first argued that the Cas9 mRNA was not optimally transcribed, thus the obtained mRNA 
was run on gel electrophoresis before each injection.  
 
 
 
Figure 21: The CRISPR/Cas system method targeting the ntl gene. (A) Representation of the 
target sequence of the gene ntl (gRNA in purple) located in the exon 1 after the ATG (red) and 
directly followed by the PAM sequence (TGG). The Cas9 protein is shown in grey. (B) A scheme 
showing the pDR274 expression vector containing the T7 promoter and the kanamycine resistance 
(Kan
R
) with 2 recognition sites of the endonuclease BsaI. After digestion with BsaI, the annealed 
oligos are ligated into the vector and the sgRNA is transcribed in vitro. 
 
In spite of the preceding observations, a deeper analysis at the DNA level had to be done to 
confirm our suspicions. In the case of the CRISPR method, unfortunately no restriction site 
analysis, or at least rarely, could be done because of the restricted target site design which 
does not give the freedom of including a restriction site at the supposed cut region. To 
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overcome this difficulty, the T7 Endonuclease I (T7EI) assay that was also used by Hwang et 
al., was applied to detect mutations at the targeted sequence. First, the genomic DNA was 
amplified with primers flanking the target sequence. The resulting PCR products were then 
denatured and re-annealed, giving rise to different structures: homoduplexes with or without 
modifications and heteroduplexes where the mutations are revealed as mismatches, which will 
be recognized and cleaved by the T7 endonuclease. The fragments would then be separated by 
electrophoresis and the targeting efficiency analyzed on the gel.  
 
The DNA targets of 10 single embryos from three different injections and two wild-type 
embryos (uninjected) were tested with this method, but no mutations were detected. Few of 
them were still sub-cloned into pGEM T easy vector and sequenced to definitely confirm the 
absence of any mutation at the target DNA sequence. Indeed, none was observed, suggesting 
that no mutations occurred at the target region of the ntl gene. A second designed gRNA 
against ntl was also tested, leading to the same observations.  
Considering that other laboratories had also difficulties to obtain positive results with the 
same Cas9, another protein, from Hruscha et al., was obtained and tried. The difference with 
the previously used protein was that the wild type Cas9 of S. pyogenes was modified by 
adding two NLS at both ends and recombined into a pCS2 vector harboring the SP6 promoter 
(Hruscha et al. 2013). We considered that two NLS at the beginning and the end of the protein 
would probably optimize its nuclear transport and thereby its efficiency.  
 
The same gRNA targeting the ntl gene was injected into one cell stage embryos together with 
the newly used Cas9 mRNA, at 2.4 µg/µl and 0.5 µg/µl respective concentrations, according 
to the proposed protocol (Hruscha et al. 2013). As to be expected from the high injected 
amount of mRNAs, a lot of malformed embryos were observed, but no specific ntl phenotype 
could be detected. The T7 endonuclease assay and sequencing analysis were performed but 
unfortunately without any success.  
 
Afterwards, a synthetically developed Cas9 from Chen’s group was successfully used in 
zebrafish and we decided to test its efficiency in our laboratory (Jao et al. 2013b). The coding 
sequence of the Cas9 of S. pyogenes was synthesized with codon optimized usage for 
zebrafish and two SV40 large T-antigen NLS were added at the N-terminal and the C-
terminal regions. This sequence was cloned into pT3TS vector carrying the T3 promoter and 
consequently named pT3TS-nCas9n (Addgene, plasmid #46757). Following the given 
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protocol, the in vitro transcribed mRNA of both T3-Cas9 and the gRNA against the ntl gene 
were injected into one cell stage zebrafish embryos with the following concentrations: 12,5 
ng/µl (~25 pg) of the gRNA and 75 ng/µl (~150 pg) of the Cas9 mRNA.  
 
 
Figure 22: Disruption of the ntl gene with the CRISPR system. (A) At 72 hpf, a ntl phenotype is 
shown in the lower panel with the lack of the posterior part, compared to a wild type uninjected 
embryo (wt). (B) Representation of the percentage of counted embryos injected with gRNA against 
the ntl gene compared to uninjected embryos. Observations at 24 hpf of the embryos under 
stereomicroscope in 3 independent experiments indicate the presence of a ntl phenotype in about 35% 
of the fish (green). The counts of normal looking and dead embryos are also represented (blue and 
purple, respectively). (C) Gel electrophoresis showing the amplified target sequence of 426 bp from 
wild type and injected single embryos, subjected to the T7 assay. A cut band representing an indel 
recognized by the T7EI is observed in the DNA of the embryo 1, whereas just the whole amplified 
sequence is observed in the wt uninjected embryo and a non mutated embryo 2. (D) An example of a 
sequencing result observed at the target site with a 7 bp deletion (red), compared to a wt control.  
 
Observations after 24 hpf showed the long-awaited specific ntl phenotype with the disruption 
of the posterior part, as previously described. Observations in three independent experiments 
showed that the ntl phenotype was detected in approximately 35% of the injected embryos 
(Figure 22B). Further analyses were performed on amplified fragments from the genomic 
DNA of single embryos using the T7 endonuclease assay. The results showed indeed 
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additional bands corresponding to a cleavage at the target site (Figure 22C). The PCR 
products from positively cleaved DNA fragments were sub-cloned into pGEM T easy vector 
and sequenced to examine the mutation types. Indeed, insertions and deletions were observed 
at the target region (Example of a deletion of 8 nt in Figure 22D compared to the wt).   
 
After trying different protocols and Cas9 proteins, the CRISPR system was finally successful 
in our hands and could be used easily to target several genes of interest. 
3.3. Targeted-modification of genes implicated in zebrafish neurogenesis 
3.3.1. Id1 disruption using the TALEN technology 
A stab wound assay was established few years ago in our laboratory in which zebrafish adult 
brains were stabbed in one hemisphere using a needle, while the opposite hemisphere was 
kept intact as a control (März et al. 2011). After the identification by RNA-seq of 279 TRs 
that are misregulated upon injury, another expression screen by in situ hybridization was 
performed in order to identify the regulators that are specifically expressed in the VZ of the 
telencephalon (for possible regulation of the NSCs). More than 60 genes encoding TRs were 
upregulated in the VZ following brain injury and among them the HLH DNA-binding 
inhibitor: Id1 (Viales et al. 2015). Loss and gain of function studies, with vivo morpholino and 
DNA lipofection in the telencephalon were previously performed and suggested a potential 
role of id1 in neurogenesis and brain regeneration of the zebrafish by maintaining the 
quiescence of the NSCs (Viales et al. 2015). An in-depth study on the function of this gene 
could reveal a precise understanding of the molecular mechanisms involved in the processes 
of adult neurogenesis. However, further confirmations and dissections are needed to draw 
definitive conclusions about the role of id1. Against this background, the adoption of 
TALENs as a new gene-targeting tool to be used in zebrafish for creating a knock-out mutant 
for id1 naturally emerged as a viable option.  
TALENs against id1 were designed in the exon 1 (Figure 23A) with the Mojo Hand online 
tool and constructed according to the Golden Gate method to finally be cloned into the 
pGoldyTALEN backbone. Both left and right mRNA TALENs were transcribed in vitro 
under the T3 promoter and injected with an equal amount (100 ng/μl) into one-cell-stage 
zebrafish embryos. TALENs against the ntl gene were injected in parallel as a positive 
control. The embryos were examined at 24 hpf, but no observable phenotype was detected in 
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the Id1-TALENs injected fish, even at later points of development, while the ntl phenotype 
was clearly observed already at 24 hpf. 
 
Figure 23: Id1 targeting with TALENs. (A) Schematic representation of the id1 gene with the target 
sequence for TALENs in the exon 1 and the restriction enzyme AlwI at the expected cut site. (B) Loss 
of restriction site analysis shown on gel electrophoresis after digestion with the enzyme AlwI of the 
amplified fragment of 300 bp from the Id1 sequence (n/d). Two overlapping bands of 150 bp (cut) 
result from the digestion (d) and in TALEN injected embryos, an uncut band remains at 300 bp (1 and 
2, uncut). (C) Statistical analysis of the rate of mutated embryos in three different experiments, with 
92% positively mutated fragments. 
To assess the efficiency of the Id1-TALENs, the loss of restriction site analysis was as well 
performed, as the recognition site of the enzyme AlwI was present at the spacer region. 
Genomic DNA was then extracted from 10 single embryos at 3 dpf and the target region was 
PCR amplified with the designed primers. After submitting the fragment to AlwI digestion, 
the amplified fragment of 300 bp was cleaved resulting in two overlapping fragments of 150 
bp (Figure 23B). In wild type embryos, the cut bands were clearly observed while in injected 
embryos with Id1-TALENs a remaining uncut band was detected (Figure 23B, 1 and 2). The 
loss of restriction site was observed by gel electrophoresis in more than 90% of the tested 
embryos, suggesting the presence of mutations at the recognition site of the enzyme (Figure 
23C).  
In order to confirm this result, positive fragments were sub-cloned into pGEM T easy vector 
in order to sequence the DNA of interest, and more than 50% of the sequenced clones (n=14) 
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exhibited indels at the desired sequence (insertions and deletions of different sizes). An 
example is shown in Figure 24A with a deletion of 13 bp in the mutated sequence compared 
to the wild type. The line followed to predict the loss of function of a mutated Id1 protein was 
to focus on the HLH motif and check if the mutations would disrupt or truncate the activity 
domain of Id1. This was done in silico: i.e. firstly by translating the mutated sequence of the 
gene, variable numbers of amino acids are obtained for each different mutation. Then, the 
peptide sequence was subjected to the pfam database (http://pfam.xfam.org/) from the 
European Bioinformatics Institute (EBI) (Finn et al. 2014) in order to predict the loss of the 
active domain in the mutated protein. The best obtained mutation created an early stop codon 
in the id1 sequence and gave rise to a short peptide of 40 aa, which should lack the HLH 
domain, thus suggesting loss of activity of the Id1 protein (Figure 24B).  
 
Figure 24: Mutation analysis at the id1 target site and evidence of germline transmission. (A) 
An example of a sequenced pGEM T clone containing a positively mutated fragment, with a deletion 
of 13 bp (Mut), compared to a wild type control (WT). (B) Prediction of the consequence of 
mutations in the id1 gene with the loss of the HLH active domain. (C) Loss of restriction site analysis 
of fragments amplified from gDNA of fish from the F1 generation. Compared to the wt with only the 
overlapping cut bands of 150 bp, the positively mutated fish contain an uncut band of 300 bp (2, 3, 5). 
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As there were evidences of successful germline transmission of mutations caused by TALENs 
in zebrafish (Huang et al. 2011), the founders F0 fish injected with Id1-TALENs were raised. 
The grown-up fish were outcrossed with wild-type so that the mutations are isolated. The 
genomic DNA was then extracted from the progeny at 3 dpf (single embryos) and analyzed 
with the same loss of restriction procedure previously used. While in wild type embryos the 
amplified fragment was completely digested by the enzyme AlwI, in the progeny of the 
mutated Id1 fish the remaining uncut band was still observable in 3 out of 7 tested embryos 
(Figure 24C). Mutations were indeed identified in a number of batches of this F1 generation, 
suggesting that the mutations were efficiently transmitted to the germline in 7 out of 10 
founders. The progeny was raised according to the appropriate conditions (cf. Material and 
Methods).  
 
Figure 25: Adult fish genotyping. (A) Fin biopsy of the zebrafish consists of removing a part of the 
fish fin in order to test the genomic DNA of individuals. (B) Gel electrophoresis showing digestion of 
DNA from adult F1 generation fish. The cut bands of 150 bp represent the digestion with the enzyme 
AlwI of the amplified fragment. The uncut band of 300 bp represents the remaining band with loss of 
restriction site (5, 9, 10). (C) Fish crossing scheme since injection of the embryos with Id1-TALENs 
until obtaining of the F3 generation carrying homozygous fish.  
 
In order to identify the F1 fish that inherited mutations caused by TALENs at the id1 gene, 
genotyping was performed using genomic DNA extracted from fin clips (Figure 25A). This 
procedure consists in cutting a slice of the fish fin, according to the ethical laws for 
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anaesthesia and fish handling, and extracting the genomic DNA from it in order to 
discriminate the mutation carriers. The DNA from each fin was isolated and purified, and the 
target sequence was then amplified by PCR. Digestion with the restriction enzyme AlwI was 
performed and the results were observed on gel electrophoresis: the resulting bands are shown 
in Figure 25B. Similarly to the previously described cases, in the wild type situation (2x wt) 
all fragments were cut, whereas in some mutated fish a distinct uncut band was observed 
(mutants 5, 9, 10), reflecting the presence of mutations at the target site. 
In this way, the mutated fish were separated from the non mutated ones. They were then in-
crossed in order to obtain an F2 generation carrying mutations (Figure 25C). When the 
embryos reach adulthood, their genome was again tested by fin biopsy and the type of the 
mutation was assessed by sequencing (after sub-cloning into pGEM T vector), in order to 
verify the type of mutations leading to the inactivation of the protein Id1.  
Following the scheme used for the crossing strategy (Figure 25C), the mutants of the F2 
generation were again in-crossed and an F3 generation was obtained to get with high 
probability homozygous fish. To identify these knockout fish, the same fin biopsy procedure 
has to be performed on the adult fish in order to sequence the amplified fragments and obtain 
the mutation profile in all the cells. On the other hand, my observations of the progeny at 
early stages did not clearly show lethality as an effect of the lack of id1.  At the present time, 
these ongoing experiments did not yet give the expected results, however more fish have to be 
tested to draw any kind of conclusion.  
3.3.2. Id3 disruption using TALENs and CRISPR/Cas9 methods 
Id3 is, like Id1, a member of the HLH family of TRs. Former studies have shown 
compensatory functions of genes of the id family, especially the role of id1 and id3 is 
flagrantly redundant during mouse brain development. According to the study performed in 
1999 by Lyden et al. in which id1 and id3 were mutated, only the double knockout mice died. 
Indeed, the presence of at least one copy of id1 or id3 prevented embryonic lethality and no 
distinguishable phenotype was observed in this case (Lyden et al. 1999). Later on, Niola et al. 
performed studies on id genes by generating a conditional triple knockout of id1, id2 and id3 
that led to neonatal lethality. The loss of the Id proteins also disrupted proliferative capacity 
and self-renewal of the NSCs resulting in premature differentiation (Niola et al. 2012). 
Moreover, in a recent work of our group on differential expression of the id genes in the adult 
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brain, it was shown that four out of the five genes are expressed in the adult telencephalon: 
id1, id2a, id3 and id4 (Diotel et al. 2015). In addition, the zebrafish id genes were also shown 
in the embryo to have partially overlapping expressions, which can be correlated with the 
absence of an observable phenotype in the id1 mutated fish. It could be thus explained by a 
compensation of the function of id1 during development from the other id genes.  
Firstly, a pair of TALENs targeting the first exon of id3 was designed using the Mojo Hand 
online tool (Figure 26A). The RVDs corresponding to left and right binding arms of 16 and 17 
nt, respectively, were assembled. The spacer region of 15 nt contained the recognition site of 
the NruI restriction enzyme to be used for the identification of mutations. After in vitro 
transcription, the mRNAs of both TALENs were injected into one-cell stage embryos.  
 
Figure 26: id3 targeting with TALENs and CRISPR. (A) Schematic representation of the id3 gene 
with the target sequence for TALENs containing the NruI restriction enzyme. (B) Loss of restriction 
site analysis shown on gel electrophoresis with the amplified fragment of 440 bp (n/d) digested with 
NruI (d), giving rise to two approximately overlapping bands of about 230 and 210 bp. The positively 
mutated fish 1 and 2 contain additionally an uncut band. (C) Schematic representation of the id3 gene 
with the target sequences for two gRNAs (gRNA-1 and -2). (D) T7 assay on the amplified DNA 
fragments. For both gRNAs-1 and -2 cut bands are observed at the right size, compared to the wt 
control that has no cut fragments. 
 
At 3 dpf, the genomic DNA was extracted from single embryos and a targeted fragment of 
440 bp was amplified by PCR. The fragment was then suggested to restriction digestion with 
NruI and positive uncut bands were observed on gel electrophoresis, in addition to the two cut 
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bands of approximately 230 bp and 210 that are almost overlapping (Figure 26B, 1 and 2), 
compared to the wild type only cut bands. Thus, suggesting the efficiency of TALENs to 
create mutations in the id3 gene. 
 
In parallel, two gRNAs against id3 were designed in the exon 1 (Figure 26C, gRNA-1 and -2). 
The transcribed mRNAs were injected individually, together with the T3-Cas9 mRNA, into 
one-cell stage embryos. The genomic DNA from single injected embryos was extracted and 
the fragment of 440 bp containing the targeted sites was amplified using the same pair of 
primers that was used for the TALEN experiment. In order to assess the efficiency of the 
gRNAs, the T7 endonuclease I assay was performed. The results shown in figure 26D suggest 
the really good efficiency of both gRNAs. Indeed, compared to the wild type control (Figure 
26D, WT) in which one band of the aforementioned size was observed, digested bands are 
present in the case of the injected embryos with the gRNA-1 and the gRNA-2 against id3. The 
first targeting gRNA-1 was expected to give rise to two fragments of approximately 320 bp 
and 120 bp in size after digestion with the T7EI endonuclease that cuts at mutations sites. Our 
observations on the gel electrophoresis correspond to these expectations for 6 out of 8 tested 
embryos (Figure 26D, gRNA-1). In a similar way, the expected sizes of the fragments 
resulting from the targeting gRNA-2 and after digestion with T7EI would be of 155 bp and 
285 bp approximately. Also in this case, the observed cut bands on gel electrophoresis are in 
line with the expected resulting fragments, and this for 6 out of 8 embryos (Figure 26D, 
gRNA-2).  
 
In order to confirm the presence of mutations at the target site and to find an alternative to 
laborious screening for the CRISPR mutations, another method was tested. The amplified 
PCR product was directly sequenced in order to seek for mutations simply by investigating 
the chromatogram of the resulting DNA sequence. In practical terms, the sequence profile 
(AB1 format) of a wild type fragment was compared to the sequence of possibly mutated 
fragments. A good sequence is generally characterized by evenly-spaced peaks of four 
different colors corresponding to the nt and the lack of baseline “noise” (see figure 27A and 
C, representing the wt fragment). In the case of a mutated fragment, the sequencing 
chromatogram starts changing at a point; the noise increases and the peaks are disordered (see 
figure 27B and D). Naturally, the most important observation is that the change in the 
sequencing profile appears in the vicinity of the PAM in which the Cas9 is expected to cut the 
DNA (Figure 27A’ and C’). This method was tested for different fragments and it was 
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validated as a good alternative to assess the efficiency of the CRISPR/Cas9 system in a 
relatively quick manner. In addition, the use of the T7 assay showed some discrepancies from 
an experiment to another, due most likely to the enzyme itself. However, in order to identify 
the type of mutations occurring at the targeted site, sub-cloning into pGEM T easy vector 
cannot be avoided. In this context, one fragment for each targeting gRNA was cloned and 
after colony PCR, some positive clones were sequenced and deletions of different sizes were 
observed in both fragments (Figure 27B’ and D’). 
 
 
Figure 27: Identification of CRISPR mutations by sequence chromatograms. (A) Sequence 
chromatogram of the wt fragment at the target site of gRNA-1 shown in A’. (B) Sequence 
chromatogram of a mutated sequence with higher noise around the expected cut site around the PAM. 
(B’) Sequencing result of a cloned fragment with a deletion of 10 bp at the target site, compared to a 
wt sequence. (C) Sequence chromatogram of the wt fragment at the target site of gRNA-2 shown in 
C’. (D) Sequence chromatogram of a mutated sequence with higher noise around the expected cut site 
around the PAM. (D’) Sequencing result of a cloned fragment with a deletion of 7 bp at the target site, 
compared to a wt sequence. 
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Our experiments indicate a really good targeting of the id3 gene with two different methods, 
TALENs and CRISPR, even though the efficiency and the time needed shifts the balance 
towards the CRISPR system for more simplicity and timeliness.  
3.3.3. Sox1 gene disruptions using the CRISPR/Cas9 technology in a multiplexed 
manner 
The genes sox1a and sox1b are closely related genes that might characterize a new subtype of 
interneurons in zebrafish: V2c in the ventral spinal cord, which was identified in mouse in 
2009 by Panayi et al.. Previously performed expression analyzes by Yang and colleagues 
showed that a proportion of sox1a/b expressing cells are different from V2b interneurons as 
they just partially co-express the same markers. Also, an increase in V2b cells was observed 
when sox1a and b are downregulated by MOs knockdown, suggesting that these two genes 
might be cell fate regulators of the V2c interneurons. Hence, further genetic studies have still 
to be performed in order to confirm these observations and to draw conclusions about cell fate 
determination in the ventral spinal cord and the molecular mechanisms implicated in the 
specification of V2c interneurons. 
 
To that purpose, two gRNAs fulfilling all the criteria were designed in the only exon of each 
gene, sox1a and sox1b: gRNA-A1, gRNA-A2, gRNA-B1, gRNA-B2 (Figure 28A). Each one 
of the gRNAs was tested individually by injection into one-cell stage embryos together with 
the T3-Cas9. No striking phenotype was observed in any of the injected embryos. However, 
the T7 endonuclease assay analyzes were performed for each of the injected gRNAs. For each 
gene, one gRNA was identified as functional, the gRNA-A2 and the gRNA-B2, for sox1a and 
sox1b respectively (Figure 28A).  
 
The two efficient gRNAs were then co-injected with the T3-Cas9 mRNA in order to target 
both genes simultaneously. After extraction of genomic DNA from single embryos, both 
fragments from sox1a and sox1b were amplified and the T7 assay was performed. 
Observations on the gel electrophoresis showed the presence of cut bands in a number of 
injected embryos, compared to the wild type and two embryos injected only with the T3-Cas9 
mRNA. Moreover, mutations were indeed detected in either target sequences and in the same 
tested embryo (Figure 28B, 5). Both fragments from the positive embryo were sub-cloned into 
pGEM T easy vector to be sequenced. Sequence analysis confirmed the presence of mutations 
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at the targeted region for both genes: 32 nt deletion in sox1a and 4 nt deletion in sox1b, both 
leading to shortened proteins. Actually, our observations conclude that the multiplex gene 
targeting is possible in zebrafish with two different gRNAs targeting two different genes.  
 
 
Figure 28: Targeting sox1a and sox1b with CRISPR. (A) Schematic representation of the sox1 
genes with the target sequences for two gRNAs for each (gRNA-A1 and -A2, gRNA-B1 and gRNA-
B2). (B) T7 assay on the amplified DNA fragments from embryos co-injected with both gRNA-A2 
and gRNA-B2. Cas9-1 and 2 represent embryos injected only with T3-Cas9 mRNA. For both sox1a 
and sox1b genes, cut bands are observed at the right size, compared to the wild type control that has no 
cut fragments (W) and to the Cas9 negative controls. The injected embryo 5 shows mutations for both 
genes and the fragments derived from this embryo were sub-cloned into pGEM T easy vector to be 
sequenced. Examples of sequencing results show a 32 bp deletion in sox1a and 4 bp deletion in sox1b 
(red). 
 
The injected embryos with both gRNAs were raised under controlled conditions and at adult 
stage, fin biopsies were performed in order to discriminate the positively mutated fish. After 
extracting the genomic DNA from the pieces of each fin, the T7 assay was performed and a 
number of positively mutated fish in both genes were identified. An example is shown in 
figure 29A, in which the fish 5 and 6 show indeed cut bands in both sox1a and sox1b 
fragments, expressing the presence of mutations at the target sites. The positive identified fish 
were isolated and some of them were outcrossed with wild type fish in order to obtain the F1 
generation.  
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Figure 29: sox1a and sox1b mutations in adults and germline. (A) T7 assay performed after fin 
biopsy on adult fish raised after injection of both gRNAs against the sox1 genes. Both 5 and 6 fish 
show the presence of mutations in both genes (blue frame). (B) T7 assay performed on embryos from 
the F1 generation derived from outcrossing. Cut bands suggesting mutations are observed in both 
genes (sox1a 1, 3 6 and sox1b 5, 7, 8), compared to the wild type controls (wt, 1 and 2). 
 
 
To the purpose of verifying germline transmission of the mutations in the sox1 genes, 
embryos from the F1 generation were tested by T7 assay. Indeed, cut bands were observed in 
some of the embryos compared to the wild type fragments, suggesting the effective 
transmission of mutations (Figure 29B: 1 and 6 for sox1a, 7 and 8 for sox1b). However, at 
that point no tested embryo contained mutations in both genes.  
 
The obtained results on the multiplexed targeting of both sox1a and sox1b genes open the 
door to expanded investigations on related genes that could have redundant functions.  The 
knockout of these genes could give the opportunity to follow their effect on the development 
of neurons in the spinal cord, especially the different sub types of interneurons that we are 
interested in.  
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Chapter IV: DISCUSSION 
 
Reverse genetics in zebrafish revolutionized both the way of performing functional studies on 
genes and the understanding of their implication in different molecular mechanisms in the 
cell. First with TILLING and antisense morpholinos, a great number of genes were identified 
for their role in vertebrate development (Moens et al. 2008; Knowlton et al. 2008). 
Afterwards, the development of gene targeting approaches in zebrafish opened the door for 
further specific studies, as almost any sequence of the zebrafish genome can be modified with 
TALENs or CRISPR methods (Hisano et al. 2014).  
 
4.1. Efficient implementation of the TALEN technology for the disruption of targeted 
genes implicated in neurogenesis in zebrafish 
TAL effector nucleases are fusion proteins containing the DNA binding domain of TAL 
effectors derived from a bacterial plant pathogen and the catalytic domain of the endonuclease 
FokI. The flexible design of TAL binding domains allows the targeting of any desired 
sequence in the DNA that is then cut by the FokI protein creating DSBs. Hence, the DSBs are 
consequently repaired via an error-prone pathway, i.e. NHEJ creating indels at the target sites 
or by HR if a template is available.   
At the beginning of this project, less was known about the routine use of the TALEN 
technology. First of all, I successfully set up and tested the method within our laboratory. A 
library of modules containing the different RVDs and backbones developed by the Voytas 
group was used (Cermak et al. 2011) and the assembly of designed TALENs was performed. 
The Golden Gate assembly method was used to construct the custom TALENs (Engler et al. 
2009). As for my experience, some issues can occur during the procedure, especially 
concerning the library of modules that has to be carefully manipulated and organized. A good 
positive control was necessary in order to test de novo TALENs and to that purpose the ntl 
gene with its clear phenotype was a perfect candidate. In fact, my first success with the 
TALEN method required the correct assembly of desired RVD modules using the Golden 
Gate method to target the ntl gene and the use of the pGoldyTALEN backbone containing a 
truncated version of the TAL cassette (Bedell et al. 2012). Approximately one week is needed 
to obtain a ready-to-use TALEN. After assessing the mutations at the target site using loss of 
restriction site analyses and sequencing, I could attest the efficiency of my custom TALENs.  
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After demonstrating that the TALEN technology can be successfully used to disrupt chosen 
zebrafish genes, my first preferred gene that was targeted was id1. Id1, the DNA-binding 
protein inhibitor 1, is part of the helix-loop-helix family of TRs that are dominant negative 
regulators of basic HLH TFs. It was shown to be involved in adult neurogenesis and brain 
regeneration, most likely by maintaining the neural stem cell pool by regulating the balance 
between quiescence and proliferation of NSCs, joining some findings in the adult mouse 
(Viales et al. 2015; Jung et al. 2010; Niola et al. 2012). TALENs against id1 successfully 
induced mutations at the target sequence resulting in several types of indels (deletions of 4 to 
13bp, insertions of 14 or 27 bp). The efficiency rate of mutations that I obtained reached up to 
90% of tested embryos, which is within the range of published results using TALENs in 
zebrafish (Dahlem et al. 2012; Bedell et al. 2012; Ma et al. 2013). However, the TALEN-
mediated mosaic mutations make it difficult to predict an effect on a given gene. Moreover, 
our results suggest that the efficiency may vary from one locus to another and possibly the 
different indel sizes can also have an effect, as for non-trinucleotide mutations that lead to 
frameshifting. I could as well assume that individual TALENs could have different activities 
(architecture, context dependency…).  
The mutations are effectively inheritable, thus different transgenic lines were obtained by 
mating the TALEN-injected founder fish with wild type animals.  Indeed, 70% of those mated 
couples gave rise to a positively mutated F1 progeny, attesting of the genetic inheritance of 
the alterations. After identification of positive mutation carriers, F1 fish were in-crossed in 
order to obtain the F2 generation of mutated fish. DNA sequencing and domain prediction 
platforms were used to identify the type of mutations that can lead to truncated proteins that 
lack the HLH domain that is the active protein-protein interaction domain of the Id proteins. 
In this context, the last obtained F3 generation of fish should most probably contain mutants 
with homozygous mutations.  
Obtaining a knockout id1 mutant will allow further studies to be done in order to understand 
the molecular mechanisms in which id1 is involved. For instance, the observed results after 
vivo-morpholino injection can be strongly confirmed in a mutant. In addition, the stab wound 
assay can be performed in adult fish brains lacking Id1 to observe the effect on the neuronal 
regeneration occurring in the zebrafish telencephalon.  
During the current study, I did not observe any phenotype in the zebrafish embryos mutated 
with id1-TALENs. A reasonable explanation was either a maternal mRNA contribution that 
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was lightly shown for this gene in zebrafish (Harvey et al. 2013), or a possible redundancy of 
other id genes that can compensate the role of id1 during development. In mouse, it was 
indeed shown that knocking out id1 or id3 separately has no observable effect on the brain 
and no significant developmental defects, while the double knockout of both id1 and id3 
genes leads to a smaller brain size and embryonic lethality (Lyden et al. 1999). Furthermore, 
other studies using conditional triple knockout mice for id1, id2 and id3 led to neonatal 
lethality and showed a defect in proliferation and self-renewal of NSCs (Niola et al. 2012). 
Also, in order to determine possible interferences between the id genes, other members of the 
Id family were added to our list of target genes in this study. Hence, I used TALENs against 
the id3 gene and attested of their efficiency according to the presence of mutations at the 
target site. I also successfully demonstrated the germline transmission of mutations in the id3 
gene. Future plans include also obtaining a knockout fish line for the id3 gene, making it 
possible to cross both id1 and id3 mutant lines in order to get double knockout fish allowing 
the study of possible effects that can have both genes on their respective functions. 
Meanwhile, a recent study of our group was performed by in situ hybridization and showed 
the expression of other id genes in the adult zebrafish telencephalon (Diotel, Beil, et al. 2015). 
It was determined that, beside id1, id2a is also expressed in type 1 and type 2 neural 
progenitors in addition to its expression in type 3 cells. Thus, id2a makes a promising future 
candidate in studying the role of the id genes in adult neurogenesis and brain regeneration in 
the zebrafish. 
Furthermore, a possible lethality caused by the knockout of id1 could not yet be ruled out 
even if it was not observed at embryonic stages. Therefore, more statistical analyses should 
help to determine if the complete lack of id1 can indeed cause the premature death of the fish. 
4.2. Efficient implementation of the CRISPR technology for use in zebrafish and 
disruption of targeted genes implicated in neurogenesis 
 
During the progress of using the TALEN method within my project, another DNA editing 
technology has emerged: the CRSPR/Cas9. This method is based on the design of short single 
guide RNAs that target a specific sequence in the DNA and recruit the endonuclease Cas9 
which induces DSBs. Like for the TALENs, the DSBs will be repaired by NHEJ thus creating 
indels in the target sequence or by HR if a DNA template is present. This attractive 
technology has fast aroused a great interest, especially among the zebrafish community. 
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Indeed, taking into account the simplicity and the rapidity of designing and constructing a 
sgRNA compared to a TALEN, it was clearly a good opportunity to be taken. In this sense, 
we decided to establish this method in our laboratory, as it could allow the disruption of a 
great number of targets in a faster way and the investigation of a large number of DNA 
sequence variants when using different gRNAs to target a single gene. At first, I successfully 
tested the CRISPR method using the ntl gene as a control considering that it was conveniently 
used for TALENs.  
 
Our interest in the CRISPR technology had grown even more with the possibility to use the 
cited method in a multiplexed manner in order to knockout several genes in the same time 
(Jao et al. 2013a). Having in mind the disruption of the different id genes, several gRNAs 
were designed in order to be tested. First tested individually, gRNAs against id3 were 
successfully used with an efficiency up to 80% of the analyzed embryos. However, the 
preliminary results concerning id2a and id4 were inconclusive and broader experimental 
expertise is needed in order to select efficient gRNAs against these genes.  
 
In parallel, I was interested in two related genes, sox1a and sox1b, that have a role in the 
specification of interneurons in the spinal cord. Indeed, sox1a and b were detected in the 
systematic screen for TRs that was performed in 24 hpf zebrafish embryos (Armant et al. 
2013). Both genes are expressed in cells of the ventral spinal cord and experimental evidences 
with morpholinos suggest their implication in the specification of a newly discovered sub-
type of interneurons in the zebrafish: V2c (Yang et al., unpublished data). These data are also 
consistent with the mouse model in which the Sox1 TF was shown to be required for the V2c 
subtype derived from the p2 domain in the ventral spinal cord (Panayi et al. 2010). In order to 
target both genes simultaneously, the CRISPR method seemed to be the most appropriate. 
Two efficient gRNAs were used and I could without contest prove the efficiency of the 
CRISPR method for multi-targeting. The mutations carrier fish for both genes were identified 
and their progeny will allow us to obtain a double knockout of sox1a and sox1b, making it 
possible to assess more deeply the function of these genes. The observations that were 
previously made with knockdown studies, including the increase of V2b cells supposedly a 
substitution for non formed V2c cells, can be confirmed and the molecular mechanisms 
inducing the specification of these interneurons can be then determined in a stronger way with 
mutants.  
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My results suggest indeed that the CRISPR technology is the most suitable to use in a casual 
manner because of its straightforward and fast application. Moreover, the overall mutation 
efficiency obtained with the CRISPR was higher than for TALENs according to my 
observations. Nevertheless, the efficiency rate, like for TALENs, may also be locus specific 
or related to the used gRNA. Indeed, a number of gRNAs did not give any positive results 
while other gRNAs targeting the same genes were really efficient.  
 
4.3. TALEN vs. CRISPR: comparison between the two used site-specific nuclease 
technologies 
 
After setting up both DNA editing methods in our laboratory, pro and cons of three crucial 
aspects were compared: 
 
- Design and construction 
The CRISPR gRNAs target sites have to be in the direct vicinity of the PAM (NGG) site and 
in addition a 5’-GG is required in order to successfully transcribe the gRNA in vitro (using 
the T7 polymerase). Other restrictions can be added as it was shown in the publication of 
Gagnon et al., in which more than 100 gRNAs were tested. They indeed observed that a 
guanine adjacent to the PAM and 50% of GC-content improve the efficiency for the target 
site. They also affirm that using the Sp6 polymerase for in vitro transcription allows more 
flexibility as it is equally efficient to transcribe 5’GG- or 5’AG gRNAs (Gagnon et al. 2014).  
Contrarily to the CRISPR, the TALEN design requires two binding proteins separated by a 
defined spacer, of 15 to 16 bases, with a thymine at position 0 of the target sequence. 
However, it was shown that the 5’-T may not be required for artificially designed TAL 
effectors in contrast to the naturally occurring ones (Meckler et al. 2013; Jankele & Svoboda 
2014).  
Regarding construction, the TALEN method is based on the modular assembly of varying sets 
of RVDs that is performed in two steps (1
st
 assembly and 2
nd
 assembly) for each TAL binding 
site; considering that a pair of TALENs is needed to allow the FokI endonuclease to dimerize 
and create DSBs in the DNA. The modules are part of a large library of more than 70 
elements. For an average laboratory without high-throughput competence, approximately one 
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week is needed to obtain the final pair of TALENs, without including the time needed to 
sequence the constructs.  
On the other hand, creating a gRNA of 20 bp is far less complex. Two overlapping 
oligonucleotides are required with an expression vector and a Cas9-containing plasmid. 
Hence, less than 3 days are needed to obtain a ready-to transcribe gRNA.    
- Specificity 
High target site specificity can be achieved with TALENs or CRISPR allowing precise gene 
editing. For the CRISPR, a gRNA recognizes a target sequence in the DNA directly followed 
by the PAM and guides the Cas9 endonucleases to cut both strands. Even if high efficiencies 
were reported with this method, there is a concern about a high rate of off-target sites as 
gRNAs can tolerate up to five mismatches (Fu et al. 2013; Kuscu et al. 2014). In order to 
counteract this issue, strategies were developed to significantly improve the specificity of the 
CRISPR: One method uses a Cas9 nickase that mutates a single-strand in the DNA and allows 
more specificity if used in a pair wise manner in which two opposing gRNAs are required to 
induce mutations at the target site located in between. Even though the nickase can still 
recognize off-targets, but the result is less mutagenic than DSBs (Mali et al. 2013b; Ran et al. 
2013). Another strategy consists of using a pair of gRNAs to recruit an inactive Cas9 fused to 
the FokI endonuclease (RFN) which considerably reduces off-target mutations (Tsai et al. 
2014). Fu et al. also advise to use shorter gRNAs of about 17 nt to reduce off-target effects 
(Fu et al. 2014).   
Concerning TALENs, the off-target effect is less of a concern, as it consists of DNA-binding 
proteins composed of a succession of RVDs that recognize an average of 17 nt. Thus, a pair of 
TALENs flanking a spacer region of 15 nt represent a rather long binding region that is 
unlikely to be recognized more than once in the genome (approximately 34 nt).  
Very often, off-targeting activity correlates with cytotoxicity since it leads to unwanted 
genomic modifications and thus it can affect the awaited results. Therefore, the specificity of 
engineered endonucleases is of a great concern when developing these strategies. The issue of 
off-targeting was addressed in several studies using different approaches to identify off-target 
mutagenesis using engineered nucleases. For instance, a method was applied by Wang et al., 
in which Integrase Defective Lentiviral Vectors (IDLV) were used to mark the resulting DSBs 
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from TALENs and CRISPR (Wang et al. 2015). They observed no off-target effects for 
TALENs and dCas9, while half CRISPR/Cas9 showed off-targets in a dose-dependent 
manner. Otherwise, ChIP-Seq analyses were also used to identify the bound sequences by the 
CRISPR (Kuscu et al. 2014; Wu et al. 2014). Deep sequencing and whole-genome sequencing 
were greatly used to collect data concerning off-target effects of these methods. Moreover, 
potential misrecognized sites can be predicted in silico using suitable algorithms that are used 
in most online tools, such as CHOPCHOP that can predict off-targets for both CRISPR and 
TALENs (Montague et al. 2014b). 
Nonetheless, the problem of off-targeting is also influenced by the delivery approach. Indeed, 
using mRNA or purified proteins reduces the off-target effects, compared to transfection of 
plasmids usually used in cells, probably because of the time of expression and the shorter 
activity duration of the nucleases (Maggio & Gonçalves 2015; Kim et al. 2014). In zebrafish, 
a recent publication showed a low risk of off-targeting activity in vivo using the CRISPR 
method (Cas9 mRNA) (Varshney & Burgess 2014). It was also shown that mistargeting is 
correlated with the dosage of the CRISPR/Cas9. Also, lowering the amount of injected 
mRNA is of great help in order to minimize off-targets (Fu et al. 2013; Ansai & Kinoshita 
2014; Wang et al. 2015). 
- Efficiency 
Both TALENs and CRISPR efficiently target and modify the genome. Evaluating this ability 
is still hardly feasible. Actually, the efficiency is measured according to the mutation events 
generated by NHEJ or HR, thus highly depending on the used cell system beside the different 
mode of action of each nuclease. More accurate analyses should be performed in a high-
throughput manner with different engineered endonucleases and within the same system 
(Hendel et al. 2014). Yet a rough comparison between the large library of publications shows 
a higher efficiency of the CRISPR method to induce mutations compared to the TALENs 
(Hwang et al. 2013; Dahlem et al. 2012; Chen et al. 2014), although both can exceed a rate of 
50% in zebrafish (Cade et al. 2012; Hwang et al. 2013). However, but unsurprisingly, the 
modified CRISPR systems optimizing specificity (e.g. Nickases and RFN) show reduced 
mutation efficiency. 
Another difference that can affect efficiency is that TALENs, unlike CRISPR, are sensitive to 
cytosine methylation, which sometimes leads to a lower or no activity at all (Bultmann et al. 
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2012; Valton et al. 2012; Hsu et al. 2013; Wu et al. 2014). Nevertheless, in some cases, 
genome editing can be hardly achieved by both methods and the reason is most probably the 
sensitivity to chromatin structure as the target sequences have to be accessible to the 
nucleases.  
On the other hand, the CRISPR/Cas9 can be efficiently and easily used in a multiplexed 
manner in order to target several genes simultaneously (Cong et al. 2013; Jao et al. 2013b; 
Wang et al. 2013). As for TALENs, two pairs can also be used to delete large genomic 
fragments, but the large size of the proteins can be of a concern (Ma et al. 2013; Xiao et al. 
2013). Moreover, the construction and the testing of multiple pairs of TALENs can be 
complicated and laborious to achieve. 
 
Table 1: Different aspects of comparison between the TALEN and the CRISPR technologies. 
In conclusion, both TALENs and CRISPR methods are valuable to create permanent DNA 
modifications with relatively high but variable efficiencies. TALENs can be designed to target 
any sequence of the genome without major constrains and with high specificity. However, 
TALEN construction is more complicated and more costly than obtaining a ready-to-use 
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gRNA. Choosing one method over the other depends on the attempted application and on the 
sequence that is to be targeted (Table 1). 
4.4. Programmable site-specific nucleases revolutionize reverse genetics in zebrafish 
For a long time, the morpholino anti-sense technology monopolized the area of gene function 
studies in the zebrafish. It was indeed an accessible method, widely used for gene knockdown 
in the zebrafish community. But the unexpectedly fast development of efficient genome 
editing technologies raised questions about the effectiveness of morpholino knockdowns. It 
was already clear that MOs can bind to non-specific targets leading to artifacts and false 
phenotypes. Even with the application of precautionary measures, such as mRNA rescue or 
suppression of p53 activity, the distinction between specific and unspecific phenotypes was 
still difficult (Schulte-Merker & Stainier 2014). On top of this, recent studies claim that a 
great number of phenotypes caused by MOs did not correspond to the mutant ones (Kok et al. 
2014; Law & Sargent 2014; Stainier et al. 2015). Indeed, Kok et al. generated mutant lines for 
24 genes using ZFNs, TALENs and CRISPR and only a small number had caused a 
phenotype. Moreover, after comparison of available data from ZFIN and the Sanger Zebrafish 
Mutation Project (ZMP), they observed discrepancies between morphants and mutants in 
approximately 80% of the cases (Kok et al. 2014). It is likely that the pseudophenotypes 
generated by MOs are caused by off-target effects and even rescue experiments cannot 
guarantee their specificity. However, the MO antisense technology can still be used in 
parallel, preferably in addition to a genetic mutant (e.g. double mutants) while keeping a 
critical eye when characterizing a new phenotype.  
In closing, emergence of site-specific nuclease technologies opens a wide range of 
applications for studying complex gene functions in animals that were so far not accessible 
for targeted gene knockout technology. Additionally, both TALENs and CRISPR methods 
cleared the road for using knockin technologies in zebrafish. Indeed, several publications 
report nowadays successful DNA integration by HR-mediated genome editing or via 
homology independent repair (Zu et al. 2013; Chang et al. 2013; Auer et al. 2014; and for 
review see Auer & Del Bene 2014).  
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4.5. Conclusion and perspectives 
 
The fast development of site-specific mutagenesis in the last few years caught great interest, 
especially from the zebrafish community that was in need of more accessible targeted genome 
editing tools. TALENs and CRISPR methods were implemented and their efficiency in 
zebrafish was showed in this work. Having in mind the understanding of the molecular 
mechanisms that control neurogenesis and regeneration in the zebrafish brain, TRs with 
promising preliminary results were selected for investigation. Thus, I targeted several id genes 
that are involved in adult neurogenesis: id1 was mutated with TALENs and three generations 
of fish were tested for germline transmission. Mutations in id3 were demonstrated with both 
strategies and heritable mutations were proven. The id2a and the id4 genes were also targeted 
with the CRISPR method without yet finding efficient gRNAs. Having in hand mutants for 
each of the id genes, deeper investigations can be performed in the future to understand their 
role in adult neurogeneis and regeneration of the zebrafish brain. Hence, by using expression 
studies and the stab wound assay that was successfully employed in our laboratory, the effects 
of the different knockouts on these processes can be monitored. Moreover, creating 
combination lines will allow the study of possible functional redundancies for these genes.  
 
On the other hand, previous studies in the ventral spinal cord of the zebrafish led to the 
highlight of two related genes, sox1a and sox1b. They were suggested to play a role in the 
specification of a newly observed sub-type of interneurons in the zebrafish, named V2c. This 
class of interneurons that was already identified in mouse has still to be investigated in 
zebrafish as little is known about its function. Taking advantage of the multiplex targeting of 
the CRISPR method, both genes were efficiently mutated simultaneously. A null background 
for the two genes will be used to confirm previous observations and to measure the role of 
sox1a and sox1b in the fate determination of the V2c interneurons.  
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Supplementary information 
The Golden Gate Kit 
S.1: RVD modules, intermediate arrays and final backbones from the Voytas group (Cermak 
et al. 2011). 
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S.2: Primers for PCR and sequencing 
 
Primer name Primer sequence 
pCR8_F1 TTGATGCCTGGCAGTTCCCT 
pCR8_R1 CGAACCGAACAGGCTTATGT 
TAL_F1 TTGGCGTCGGCAAACAGTGG 
TAL_R2 GGCGACGAGGTGGTCGTTGG 
SeqTALEN_5-1 CATCGCGCAATGCACTGAC 
 
 
 
